History of Cannabis Book
The Complete History of Cannabis
From the steppes of Central Asia to the modern world – a plant’s journey through ten thousand years of human civilisation.
Prologue: The Plant and the People ↑
On a cool morning in the Altai Mountains of Siberia, sometime around the fifth century BCE, a young woman lay down for the last time. She was perhaps twenty years old, dressed in a long wool skirt and a silk blouse—imported luxuries that spoke to the wealth and connections of her people, the Pazyryk nomads. Her body was placed inside a log coffin carved from a single larch tree, and beside her, mourners arranged a small leather bag containing several handfuls of coriander seeds, a bronze mirror, and a collection of what appeared to be burned plant material. When archaeologists excavated her tomb in 1993, preserved by the permafrost, they found that the plant material was cannabis. More remarkably, they discovered a small tent made of felt, propped up on poles, containing a bronze censer filled with stones that still bore traces of cannabis resin and psychoactive compounds. The tent had been sealed within the tomb, and the woman—now known as the Siberian Ice Maiden—had been buried with everything she might need for the journey ahead.
The Ice Maiden's cannabis was not an anomaly. Two thousand miles to the east, in the Taklamakan Desert, the so- called Cherchen Man, a Caucasian mummy dating to 1000 BCE, was found buried with a leather pouch containing cannabis leaves and seeds carefully arranged near his head. Three thousand miles to the south, in the Egyptian city of Thebes, a papyrus from 1550 BCE prescribed cannabis for inflammation, while five thousand miles to the east, in Neolithic Taiwan, potters had been incorporating hemp fibers into their clay vessels for more than two thousand years. The plant that would become one of the most controversial substances in human history had already been woven into the fabric of human civilization for millennia before any of these people lived. It had clothed bodies, healed wounds, altered consciousness, and accompanied the dead into the afterlife.
This book is the story of that plant. It is not a story of a simple substance that happens to have psychoactive properties, nor is it a polemic for or against its modern use. It is, instead, a history of how a single botanical species—Cannabis sativa—became entangled with human ambition, human need, human fear, and human desire across ten thousand years of civilization. It is a story that moves from the steppes of Central Asia, where the plant first evolved, to the palaces of ancient China, where emperors debated its medicinal virtues; from the hashish dens of Ottoman Cairo, where poets composed odes to its pleasures, to the ropewalks of British naval yards, where hemp fibers made imperial expansion possible; from the Mexican border towns where American soldiers first encountered "marihuana" in the early twentieth century, to the suburban American basements where the medical cannabis movement was born in the shadow of AIDS and cancer; from the prison cells where millions have been incarcerated for its possession, to the corporate boardrooms where executives now calculate quarterly earnings from its sale.
Throughout this history, cannabis has been many things to many people: a sacred sacrament and a dangerous vice, an indispensable industrial commodity and a threat to social order, a therapeutic miracle and a cause of madness, a symbol of countercultural rebellion and a mainstream consumer product. These competing meanings have never been simply about the plant itself. They have been about who uses it, in what contexts, under what laws, and with what social and economic consequences. The history of cannabis is, in this sense, a mirror held up to the societies that have regulated it, a lens through which we can examine questions of race, class, power, medicine, commerce, and human freedom.
Part I: The Plant
Chapter One: Taxonomy, Biology, and the Puzzle of Classification
The cannabis plant presents botanists with a paradox: it is at once one of the most familiar plants in human cultivation and one of the most taxonomically contested. Linnaeus named it Cannabis sativa in 1753, taking the specific epithet from the Latin sativus, meaning "cultivated"—a designation that captured the plant's long history of domestication but obscured the existence of wild or feral populations that had never been intentionally planted. The generic name Cannabis itself is ancient, derived from Greek kannabis, which may have been borrowed from a Scythian or Thracian word, suggesting that Europeans encountered the plant through the nomadic peoples of the steppes.
The taxonomic confusion that would bedevil cannabis for centuries began almost immediately. In 1785, the French naturalist Jean-Baptiste Lamarck, examining specimens collected in India, proposed that they represented a distinct species, which he named Cannabis indica. Lamarck noted that the Indian plants were shorter, more branched, and more intoxicating than the European hemp he knew, which he continued to classify as Cannabis sativa. His distinction was based on morphology—the shape and structure of the plants—but it carried an implicit recognition that human selection had produced divergent forms adapted to different purposes.
For the next two hundred years, botanists argued about whether these differences merited species-level distinction or should be considered varieties of a single species. The debate was not merely academic. If Cannabis sativa and Cannabis indica were separate species, then hemp cultivation and drug production could be treated as distinct enterprises with different regulatory implications. If they were the same species, then any cannabis plant could potentially be bred for intoxicating potency, making agricultural distinctions meaningless in practice. The stakes of taxonomy became legal, commercial, and political.
In 1976, the botanist Ernest Small published a massive monograph that became the definitive treatment of cannabis taxonomy for a generation. Small argued that the morphological differences between hemp and drug types, while real, were continuous rather than discrete, and that all cultivated cannabis belonged to a single highly variable species, Cannabis sativa. He proposed three subspecies: C. sativa subsp. sativa for the tall, sparsely branched hemp varieties of Europe; C. sativa subsp. indica for the shorter, more branching drug varieties of South Asia; and a third subspecies, C. sativa subsp. ruderalis, for the feral populations of Central Asia and Eastern Europe that had escaped cultivation and adapted to short growing seasons.
The ruderalis populations are particularly interesting for understanding cannabis evolution. The name comes from ruderal, meaning growing in waste places or disturbed soils, and these plants exhibit characteristics of natural selection rather than human selection: they are small, early-flowering, and low in intoxicating compounds. Genetic analysis suggests that ruderalis may represent either the ancestral form from which both hemp and drug types diverged, or a feral derivative of domesticated plants that reverted to wild characteristics under natural selection. Either way, they illustrate the plasticity of the cannabis genome and the plant's ability to adapt to diverse environments and selective pressures.
Modern genetic techniques have complicated rather than resolved the taxonomic debates. Studies of DNA sequences have shown that domesticated cannabis populations exhibit high genetic diversity but do not clearly cluster into the species or subspecies categories proposed by morphologists. Some genetic analyses support a distinction between hemp and drug types, others show continuous variation, and still others suggest that the plants now classified as Cannabis sativa and Cannabis indica may have been independently domesticated from distinct wild populations. The most recent consensus holds that Cannabis is a single highly polymorphic species, but this consensus is provisional, subject to revision as more data accumulate.
Whatever the ultimate taxonomic resolution, the practical reality is that human selection has produced cannabis plants adapted to an extraordinary range of uses. Hemp varieties are tall, with long fibers running the length of the stem, relatively few branches, and low concentrations of psychoactive compounds. Drug varieties are shorter, more branched, with dense clusters of flowers—the reproductive structures where psychoactive compounds are most concentrated—and high concentrations of the primary intoxicant, delta-9-tetrahydrocannabinol, commonly known as THC. Between these extremes lies a continuum of intermediate types, including the plants used for fiber, seed, and psychoactive resin in various combinations across different cultures and historical periods.
Understanding this variation requires understanding the chemistry that makes cannabis so distinctive. The cannabis plant produces a family of chemical compounds known as cannabinoids, which are found nowhere else in nature in such abundance and diversity. These compounds are produced in glandular trichomes—tiny, mushroom-shaped structures that cover the surfaces of the flowers and, to a lesser extent, the leaves. The trichomes are the plant's defense system, producing sticky, bitter compounds that deter herbivores and protect against ultraviolet radiation, while also serving as a mechanism for seed dispersal by attracting animals that will spread the seeds.
The most famous of these compounds is THC, but it is only one of more than one hundred cannabinoids identified in cannabis. The second most abundant is cannabidiol, or CBD, which has no intoxicating effects but has been found to modulate the effects of THC and to possess therapeutic properties of its own. Others include cannabigerol (CBG), cannabichromene (CBC), and tetrahydrocannabivarin (THCV), each with its own pharmacological profile and potential therapeutic applications. The ratios among these compounds, along with the presence of terpenes—aromatic compounds that give cannabis its distinctive smell and also have therapeutic effects—determine the plant's effects on human consumers.
The evolutionary origins of cannabinoid production are not fully understood, but the leading hypothesis is that these compounds evolved as a form of chemical defense against herbivores and pathogens. Cannabinoids are bitter, and THC in particular has been shown to deter insect feeding and inhibit fungal growth. The fact that some cannabinoids have profound effects on the human nervous system is an evolutionary accident—a consequence of the fact that the human endocannabinoid system, which regulates mood, appetite, pain sensation, and memory, uses chemical signals similar enough to plant cannabinoids to be activated by them.
The endocannabinoid system itself was not discovered until the 1990s, centuries after humans began using cannabis for its effects on that system. This system, which exists in all vertebrates, consists of receptors (CB1 and CB2), endogenous cannabinoids (such as anandamide and 2-AG), and the enzymes that synthesize and break them down. The CB1 receptors are concentrated in the brain and central nervous system, where they modulate neurotransmitter release, while CB2 receptors are found primarily in immune cells and peripheral tissues. When THC enters the body, it binds to CB1 receptors, producing the characteristic psychoactive effects: altered perception, euphoria, increased appetite, and impaired short-term memory. CBD, by contrast, has low affinity for these receptors and works through other mechanisms, including modulating the effects of THC and acting on serotonin and other neurotransmitters systems.
The discovery of the endocannabinoid system revolutionized the scientific understanding of how cannabis works and opened new avenues for drug development. It also provided a physiological explanation for why humans have used cannabis for millennia: the plant's compounds tap into a system that is fundamental to our biology, one that we share with all mammals, birds, reptiles, and fish. The effects of cannabis on human consciousness are not accidental or anomalous but reflect deep evolutionary continuities between plants and animals.
The domestication of cannabis was made possible by the plant's genetic flexibility. Unlike many crop plants that require specific conditions to thrive, cannabis can grow in a wide range of climates and soils, from the humid tropics to the dry mountains of Central Asia. It is a fast-growing annual, capable of reaching maturity in three to five months, and it produces abundant seeds that can be stored for years. These characteristics made it an ideal candidate for early domestication, and the archaeological evidence suggests that humans began cultivating cannabis for fiber and seed at least eight thousand years ago, and possibly much earlier.
The distinction between hemp and drug types is largely a product of human selection. For millennia, farmers selected plants that produced strong fibers and abundant seeds, inadvertently selecting for lower THC content because the plants' energy went into fiber and seed production rather than resin. In other contexts—particularly in South Asia, where cannabis was valued for its psychoactive properties—farmers selected for resin production, developing varieties with high THC content and dense flower clusters. These divergent selection pressures produced the morphological and chemical differences that Lamarck observed in the eighteenth century and that continue to shape the cannabis industry today.
The geographic origins of cannabis domestication remain a subject of debate, but the evidence points to Central Asia as the center of diversity and the most likely site of initial domestication. Wild or feral cannabis populations are found from the Caspian Sea to western China, with particularly high diversity in the Hindu Kush mountains of northern Pakistan and Afghanistan. This region, which also gave rise to wheat, barley, and other founder crops of agriculture, may have been where humans first began to cultivate cannabis, perhaps initially as a weed of grain fields that was later intentionally planted for its useful properties.
The archaeological evidence for early cannabis use is fragmentary but suggestive. The oldest known cannabis fibers, dating to around 8000 BCE, have been found at the Neolithic site of Chia Te in Taiwan, where hemp was used in pottery manufacture. Hemp cord impressions on pottery from the same period have been found in China and Japan, suggesting that the plant was already being processed for fiber. By 4000 BCE, hemp textiles were being produced in China, and by 2000 BCE, cannabis seeds were being used as food and oil in Central Asia and the Middle East.
The story of cannabis domestication is thus one of gradual, geographically dispersed processes rather than a single event. Humans in different regions, with different needs and values, selected different traits from the cannabis gene pool, creating the diversity of forms we see today. This diversity is not merely of historical interest but has practical implications for modern agriculture, medicine, and regulation. The same species that can be grown for industrial fiber on a thousand-acre farm in France can be bred to produce 30 percent THC in a hydroponic grow room in California, and the legal frameworks that attempt to distinguish between them must contend with the underlying biological reality that they are variations on a common theme.
Chapter Two: Morphology, Cultivation, and the Making of Plant Types
The cannabis plant that emerges from the soil is a study in contrasts. In its hemp form, it can reach fifteen feet or more in height, with a single stout stem and few branches, the leaves arranged in a spiral pattern up the stalk. The leaves themselves are palmate—shaped like a hand with outstretched fingers—typically with five to eleven serrated leaflets radiating from a central point. This architecture is well suited to fiber production: the tall, unbranched stem produces long, unbroken fibers that run the length of the plant, ideal for spinning into rope, cordage, and textiles.
In its drug form, the plant takes a different shape. It is shorter, often no more than three to five feet tall, with multiple branches emerging from the base and along the stem. The internodes—the spaces between leaves—are shorter, producing a denser, bushier plant. The flowers, which in hemp varieties are scattered along the stem, are concentrated in dense clusters at the nodes and branch tips. These clusters, often called buds in modern cannabis culture, are covered with glandular trichomes that give them a frosty, crystalline appearance. The entire plant is optimized not for fiber length but for resin production, channeling its energy into the chemical compounds that will protect the flowers and attract the animals that disperse its seeds.
These divergent forms are not merely the result of genetics but also of cultivation practices. Hemp grown for fiber is typically planted densely—up to two hundred plants per square meter—so that the plants compete for light and grow tall and thin, suppressing branching. It is harvested when the male plants have shed their pollen and the seeds are forming, at which point the fibers are at their peak strength. Drug cannabis, by contrast, is grown at much lower densities, often one plant per square meter or less, allowing for maximum light penetration and branch development. It is typically harvested when the flowers are mature but before the seeds fully form, preserving the resinous trichomes that contain the psychoactive compounds.
The cultivation of drug cannabis has historically involved techniques that maximize resin production. Farmers in South Asia and the Middle East learned to remove male plants from the vicinity of females, preventing pollination and causing the females to continue producing flowers in an effort to attract pollen. These unpollinated flowers, known as sinsemilla (Spanish for "without seed"), produce significantly higher resin content than seeded flowers, as the plant continues to generate the sticky trichomes that would normally protect developing seeds. This technique, which may have originated in Central Asia or India, spread to other regions through trade and cultural exchange and is now standard practice in drug cannabis cultivation worldwide.
The historical geography of cannabis cultivation is a story of adaptation to local conditions. In China, where hemp was cultivated for fiber and seed for millennia, farmers developed varieties suited to the temperate climate of the Yellow River valley, with its cold winters and hot, wet summers. In India, the Gangetic plain provided ideal conditions for drug cannabis, with its long growing season and abundant moisture, while the cooler, drier climate of the Himalayan foothills produced particularly potent varieties that became famous across Asia. In the Middle East, cannabis was cultivated in oases and along river valleys, where irrigation made agriculture possible in arid environments. In Europe, hemp became a staple crop in regions with cool, moist summers, particularly in Italy, France, and Russia, where it was grown for fiber that supplied the maritime and textile industries.
The transatlantic slave trade brought cannabis to the Americas in the form of hemp. Spanish and Portuguese colonizers introduced hemp cultivation to Mexico, Colombia, and Brazil in the sixteenth century, initially for fiber to supply their colonial economies. By the seventeenth century, hemp was being grown in what is now the United States, first in New England and later in Virginia and Kentucky, where it became a major cash crop. George Washington and Thomas Jefferson both grew hemp at their plantations, and the fiber was used for rope, sailcloth, and clothing throughout the colonial and early national periods.
The drug varieties of cannabis reached the Americas through different routes. Mexican laborers brought seeds for psychoactive cannabis, known locally as "marihuana," to the southwestern United States in the late nineteenth and early twentieth centuries, where it was used recreationally and as a folk medicine. Caribbean immigrants, particularly from Jamaica, brought ganja to the United Kingdom and the United States in the mid-twentieth century, along with the Rastafari religious traditions that elevated cannabis to a sacrament. Southeast Asian varieties, known as Thai sticks or Cambodian red, entered the global drug trade during the Vietnam War era, when American soldiers encountered potent drug cannabis in the region and brought it back to the United States.
The globalization of cannabis cultivation has accelerated dramatically since the 1960s, driven by the expansion of the illicit drug trade and, more recently, by the legalization of medical and adult-use cannabis in many jurisdictions. Today, cannabis is grown on every continent except Antarctica, in climates ranging from the humid tropics to the arid deserts of the American Southwest, from the temperate valleys of Europe to the mountains of Central Asia. Cultivation methods have become increasingly sophisticated, with indoor hydroponic systems, climate control, and advanced breeding techniques producing plants with precisely controlled chemical profiles and yields that would have been unimaginable to traditional farmers.
Yet the fundamental biology remains unchanged. The cannabis plant still grows from a seed, sends down a taproot in search of water, pushes up a stem in search of light, and produces flowers in the hope of reproduction. It still responds to day length, flowering when the nights grow long in the autumn, a trait that traditional farmers exploited by planting in the spring and harvesting in the fall. It still produces the same family of chemical compounds that have made it valuable to humans for ten thousand years, even as our understanding of those compounds has deepened and our uses for them have multiplied.
Part II: Deep Origins and Ancient Worlds
Chapter Three: The First Encounters: Prehistory and the Origins of Cannabis Use
The relationship between humans and cannabis began not with agriculture but with gathering. For tens of thousands of years, Homo sapiens lived as hunter-gatherers, moving across the landscapes of Eurasia in pursuit of game and seasonal plant foods. In the course of these movements, they would have encountered cannabis growing in the wild—on riverbanks, in disturbed soils, at the edges of forests—and they would have learned to use it, as they learned to use hundreds of other plants, for fiber, food, medicine, and perhaps for altered states of consciousness.
The earliest evidence of human-cannabis interaction is indirect: the presence of cannabis pollen in sediment cores from sites where human activity is known. Pollen analysis from the Jomon period in Japan (c. 10,000-300 BCE) shows increasing concentrations of cannabis pollen associated with human settlement, suggesting that people were either cultivating the plant or creating disturbed habitats where it could thrive. Hemp cord impressions on pottery from the same period indicate that the fibers were being processed for use, though whether the plants were wild or cultivated is unknown.
The direct evidence for prehistoric cannabis use comes primarily from archaeological sites in Central Asia and China. At the site of Chia Te in Taiwan, hemp fibers were found mixed with clay in pottery dated to 8000 BCE, making them the oldest known cannabis artifacts. The fibers were used as a tempering agent, adding strength to the clay and preventing cracking during firing. This utilitarian use of hemp fibers suggests that the plant was already valued for its strong, durable fibers, which could be extracted by soaking the stems in water and then beating them to separate the fibers from the woody core—a process known as retting that has remained essentially unchanged for millennia.
By 4000 BCE, hemp textiles were being produced in the Yellow River valley of China, where the Yangshao culture left evidence of woven hemp fabrics. These early textiles were coarse by later standards but represent a significant technological achievement: the cultivation, harvesting, retting, and spinning of hemp fibers into yarn, and the weaving of that yarn into cloth. Hemp was one of the first plants domesticated for fiber, alongside flax, and it would remain a primary source of textile fiber in China for thousands of years.
The archaeological record for psychoactive cannabis use is more elusive. The compounds that produce intoxication are organic and degrade over time, making them difficult to detect in ancient remains. However, advances in chemical analysis have made it possible to identify cannabis residues on archaeological artifacts, and these analyses have pushed back the evidence for psychoactive use much earlier than previously thought.
The most striking early evidence comes from the Pamir Mountains of western China, where a 2019 study analyzed residues from wooden braziers found in tombs dating to 500 BCE. The braziers contained cannabis with THC levels significantly higher than those found in wild plants, suggesting that the cannabis had been selected for its psychoactive properties. The tombs were associated with the Jushi culture, a pastoralist society that inhabited the region in the first millennium BCE, and the presence of the braziers in mortuary contexts suggests that cannabis smoking was part of funeral rituals.
This finding aligns with the account of the Greek historian Herodotus, writing in the fifth century BCE, who described how the Scythians—nomadic peoples of the Eurasian steppe—used cannabis in purification rituals. Herodotus wrote that the Scythians would set up a small tent, place hemp seeds on hot stones, and inhale the resulting vapor, “howling with joy” as they became intoxicated. The Pamir tombs, which are located in territory that Scythian-related peoples inhabited, suggest that Herodotus was reporting accurately, and that cannabis inhalation was already a well-established practice among the pastoralist societies of Central Asia by his time.
The Ice Maiden of the Altai Mountains, mentioned in the prologue, represents another piece of this puzzle. Her tomb, dated to the fifth century BCE, contained a censer with cannabis residue, along with the felt tent that would have been used for the ritual. The presence of the tent and censer in the tomb suggests that cannabis inhalation was considered important enough to accompany the deceased into the afterlife—that it was not merely a recreational pleasure but a meaningful ritual practice with spiritual significance.
These finds from the first millennium BCE point to a long prehistory of psychoactive cannabis use among the pastoralist peoples of Central Asia. The origins of this practice are lost in time, but it is reasonable to speculate that it began when people observed the effects of the plant on animals—perhaps on deer or birds that consumed the flowers—and began experimenting with it themselves. The practice of heating the flowers or leaves to release the active compounds could have been discovered accidentally, when cannabis was thrown on a fire and the smoke produced unexpected effects. From such chance discoveries, knowledge would have spread through communities, accumulating over generations into traditions of use that were encoded in rituals, songs, and stories.
The domestication of cannabis for psychoactive use likely followed a different trajectory than domestication for fiber. Whereas fiber hemp could be grown in dense stands and harvested before the plants produced flowers, psychoactive cannabis required selection for resin production and careful management of pollination to maximize potency. The earliest centers of drug cannabis cultivation appear to have been in the Hindu Kush region of northern Pakistan and Afghanistan, and in the Himalayan foothills of India and Nepal, where the combination of high altitude, intense sunlight, and long growing seasons produced particularly potent plants.
From these centers, knowledge of psychoactive cannabis spread along trade routes, reaching China, the Middle East, and eventually Europe. The Silk Road, which connected China to the Mediterranean from the second century BCE onward, was a particularly important vector for the spread of cannabis knowledge, as merchants, monks, and travelers carried seeds and cultivation techniques across the Eurasian continent. By the first century CE, cannabis was being used for psychoactive purposes throughout much of Asia, and its reputation was spreading to the Roman world, where writers like Pliny the Elder noted its intoxicating properties.
The prehistoric relationship between humans and cannabis thus established the basic patterns that would persist for millennia: the plant was valued for its fiber, its seeds, and its psychoactive properties, and its cultivation spread from its Central Asian homeland to the major civilizations of Eurasia. The next chapters will trace how these patterns developed in specific cultural contexts, producing the distinctive traditions of cannabis use that shaped the ancient world.
Chapter Four: China: Medicine, Textiles, and the Foundations of Hemp Culture
No civilization has had a longer or more consequential relationship with cannabis than China. For more than five thousand years, the Chinese have cultivated hemp for fiber, used cannabis seeds for food and oil, and prescribed cannabis in their medical traditions. The Chinese also developed the earliest known writing systems that recorded knowledge about the plant, and their texts provide an unparalleled window into the place of cannabis in ancient society.
The archaeological record of cannabis in China begins with the Neolithic cultures of the Yellow River valley. At the site of Banpo, near Xi'an, hemp fibers have been found in pottery dating to 4000 BCE, and hemp seeds have been recovered from storage pits. The Yangshao culture, which flourished in the same region from 5000 to 3000 BCE, produced woven hemp textiles that represent some of the earliest evidence of fiber processing in East Asia. By the Longshan period (3000-2000 BCE), hemp was being cultivated on a larger scale, with seeds and fibers found at multiple sites across northern China.
The earliest written references to cannabis appear in the Shiqing (Book of Songs), a collection of poetry compiled between the eleventh and seventh centuries BCE. One poem describes women gathering hemp seeds, while another mentions a field of hemp growing lush and green. These references are casual, suggesting that hemp cultivation was a familiar part of rural life, with the seeds gathered for food and the fibers processed for clothing and cordage. The poems also contain some of the earliest evidence for the psychoactive use of cannabis, with references to states of intoxication that may have been induced by the plant.
The Erya, a dictionary compiled in the third century BCE, provides more detailed information about cannabis classification. It distinguishes between fen (hemp) and ma (cannabis), with ma referring to the female plant, which was valued for its seeds and psychoactive properties. The distinction between male and female plants was important in Chinese cannabis culture, as the female plant was known to produce more potent effects when consumed.
The most important ancient Chinese text on cannabis is the Shennong Bencao Jing (Shennong's Classic of Materia Medica), compiled in the first century CE but drawing on traditions that were centuries older. This text, attributed to the mythical emperor Shennong, who was said to have tasted hundreds of herbs to discover their medicinal properties, describes cannabis in terms that reveal its multiple uses. The entry for ma (cannabis) states that the plant is toxic but that prolonged use can cause communication with spirits and lightness of body. It prescribes the seeds for various conditions, including constipation and female disorders, and notes that the flowers are the most potent part.
The Shennong Bencao Jing also contains one of the earliest known warnings about the psychoactive effects of cannabis: if taken in excess, it causes one to see demons and to run about wildly. This ambivalent attitude—acknowledging the plant's power while warning against its overuse—would characterize much of Chinese medical writing on cannabis for centuries to come. The text reflects a culture in which cannabis was accepted as a medicine and a ritual substance but was also recognized as potentially dangerous if used improperly.
The Chinese medical tradition developed sophisticated theories about how cannabis worked, theories that were grounded in the cosmological framework of yin and yang and the five elements. Cannabis was classified as a qi tonic—a substance that affects the body's vital energy—and was thought to be particularly effective for conditions involving stagnation or blockage. Its psychoactive effects were interpreted as manifestations of its ability to move qi in the upper parts of the body, affecting the heart and the spirit.
In addition to its medical uses, cannabis played a significant role in Chinese religious and ritual life. The Taoist tradition, which emerged in the early centuries CE, incorporated cannabis into its practices of seeking immortality and communicating with spirits. Taoist texts from the fourth and fifth centuries CE describe the use of cannabis in meditation and ritual, often in combination with other substances. The Taoist master Ge Hong, writing in the fourth century, described how the consumption of cannabis could produce visions and enable communication with the dead.
Buddhism, which entered China from India in the first century CE, brought with it Indian traditions of cannabis use, though the relationship between Buddhism and cannabis in China was complex. Some Buddhist texts condemned the use of intoxicants, including cannabis, as violations of the precepts, while others tolerated or even encouraged its use in ritual contexts. The Chinese Buddhist canon includes references to cannabis as a medicine, and some Chinese Buddhist traditions incorporated cannabis into their practices, particularly in esoteric or Tantric contexts.
The economic importance of hemp in ancient China cannot be overstated. Hemp was one of the five staple grains of ancient China, along with rice, wheat, barley, and millet, and its seeds were a major source of oil and protein. The fibers were used for clothing, rope, and paper—the invention of paper in China during the Han dynasty (206 BCE–220 CE) was made possible by hemp fiber, which was pulped and pressed into sheets. Hemp paper became the standard medium for writing and printing in China, and it remained so for nearly two thousand years.
The cultivation of hemp was regulated by the state, which recognized its importance to the economy and the military. Under the Qin dynasty (221–206 BCE), hemp cultivation was encouraged by imperial edict, and taxes were levied on hemp production. The Han dynasty established standards for hemp quality and set prices for hemp products. Hemp was also used as a form of currency in some regions, with bolts of hemp cloth serving as a medium of exchange.
The Chinese cannabis tradition also included the development of specialized varieties for different purposes. Farmers in different regions selected for traits that suited their local conditions and needs, producing strains with varying fiber length, seed yield, and psychoactive potency. The mountains of Yunnan province, in southwestern China, were particularly important centers of cannabis diversity, with wild and cultivated populations that had been selected over millennia for resin production.
By the early centuries of the Common Era, China had established a comprehensive cannabis culture that encompassed agriculture, medicine, religion, and daily life. This culture would continue to evolve over the following centuries, adapting to new circumstances and incorporating new influences, but its basic contours were already in place. The Chinese experience with cannabis—practical, medical, and ritual—would influence the development of cannabis cultures throughout East Asia and, through the Silk Road, would contribute to the spread of cannabis knowledge to the West.
The Chinese approach to cannabis was characterized by a pragmatic attitude that distinguished between its different uses. Hemp was a valuable agricultural commodity, its cultivation encouraged by the state and integrated into the economy. Cannabis seeds were a nutritious food, prescribed by physicians and consumed by ordinary people. The psychoactive properties of the plant were recognized and utilized, but with caution, in medical and ritual contexts. This balanced approach, which saw cannabis as neither a sacred sacrament nor a dangerous vice but as a useful plant with both benefits and risks, would persist in China for millennia, only changing with the modern era of global drug prohibition.
Chapter Five: India: Sacred Plant, Medicine, and the Cult of Bhang
If China gave the world hemp, India gave the world ganja. The Indian subcontinent developed the richest and most complex traditions of psychoactive cannabis use in the ancient world, embedding the plant in religion, medicine, law, and daily life. Cannabis in India was not merely a substance to be consumed but a sacred entity in its own right, with its own mythology, its own rituals, and its own place in the divine order of things.
The earliest evidence for cannabis in India comes from the Vedas, the sacred texts of Hinduism composed between 1500 and 500 BCE. The Atharva Veda, the fourth of the four Vedas, contains a hymn to cannabis, calling it one of the five sacred plants and describing its use in relieving anxiety and promoting well-being. The plant is referred to as bhang, a name that would persist for thousands of years, and its properties are attributed to divine origins. According to the Vedic account, cannabis was created when a drop of nectar fell from heaven, sprouting into a plant that could bring joy and relieve suffering.
The Vedic association of cannabis with the gods was elaborated in later Hindu mythology. One popular story, found in various Puranic texts, tells how the god Shiva, the destroyer and transformer, came to be associated with cannabis. According to the legend, Shiva was walking in the mountains after a family argument when he came upon a patch of cannabis plants. He rested beneath them, ate their leaves, and felt his anger dissolve into peace and contentment. From that day forward, cannabis became his favorite plant, and his followers honor him by consuming it on festival days, particularly during the spring festival of Holi and the autumn festival of Shivaratri.
The association of cannabis with Shiva gave the plant a central place in Hindu devotional practice. Shiva is the ascetic god, the lord of yogis, who renounces worldly pleasures in pursuit of spiritual liberation. Cannabis, paradoxically, became a tool for that renunciation: by consuming it, devotees could enter altered states of consciousness that facilitated meditation and brought them closer to the divine. The logic was not that cannabis was an escape from spiritual discipline but that it was an aid to it, a sacrament that opened the door to higher states of awareness.
The mythology of cannabis in India was not limited to the Hindu tradition. Buddhist and Jain texts also mention the plant, though with varying degrees of approval. The early Buddhist monastic codes prohibited the use of intoxicants, including cannabis, for monks and nuns, but lay practitioners continued to use it for medicinal and ritual purposes. In the Tantric traditions that emerged in medieval India, cannabis became an important element of ritual practice, used to induce altered states that were understood as necessary for spiritual transformation.
The medical tradition of India, known as Ayurveda, developed an extensive literature on the therapeutic uses of cannabis. The Sushruta Samhita and Charaka Samhita, the foundational texts of Ayurvedic medicine compiled between the sixth century BCE and the fourth century CE, describe cannabis as a treatment for a wide range of conditions, including pain, inflammation, digestive disorders, and nervous conditions. Cannabis was typically prescribed in combination with other herbs, the formula carefully balanced to maximize therapeutic effects while minimizing unwanted side effects.
Ayurvedic physicians classified cannabis according to the humoral theory that underpinned their medical system. Cannabis was considered heating and drying in its qualities, making it suitable for conditions characterized by cold and damp. It was prescribed in various forms: the leaves could be chewed or smoked, the seeds could be eaten or pressed for oil, and the resin could be dissolved in milk or ghee for internal consumption. The most common preparation was bhang, a drink made by grinding cannabis leaves and flowers with milk, sugar, and spices, which was consumed for both medicinal and recreational purposes.
The Ayurvedic texts also contained warnings about the overuse of cannabis. The Charaka Samhita notes that excessive consumption can lead to confusion, dizziness, and debility, and it recommends moderation in use. These warnings suggest that the medical tradition recognized the potential harms of cannabis even as it valued its therapeutic benefits—a balanced perspective that would be lost in later centuries as Western medicine adopted a more absolutist stance toward the plant.
The social role of cannabis in ancient India extended beyond medicine and religion. Cannabis was consumed by people across the social spectrum, from Brahmin priests to untouchable laborers, though the forms and contexts of consumption varied by class. The wealthy might consume bhang prepared with expensive spices and served in fine vessels, while the poor might chew the raw leaves or smoke the flowers in a simple clay pipe. In some regions, cannabis was offered to guests as a sign of hospitality, and it was common at weddings, festivals, and other social gatherings.
The legal status of cannabis in ancient India was ambiguous. The Arthashastra, a treatise on statecraft written in the fourth century BCE, mentions cannabis in the context of taxes and regulations, suggesting that its sale and consumption were controlled by the state but not prohibited. The text prescribes taxes on cannabis sellers and establishes rules for the operation of bhang shops, indicating that the state viewed cannabis as a legitimate commercial commodity that could be regulated like other goods.
The Islamic conquest of northern India, beginning in the twelfth century CE, brought new attitudes toward cannabis, but it did not end Indian cannabis culture. The Muslim rulers of the Delhi Sultanate and the Mughal Empire generally tolerated the use of cannabis by their Hindu subjects, though some rulers attempted to restrict or prohibit it. The Mughal emperor Akbar (1556-1605) was known to be sympathetic to cannabis use, and his court physician described its medicinal benefits in detail. The Mughal period saw the flourishing of bhang culture, with sophisticated preparations and elaborate rituals developing in both Hindu and Muslim communities.
The British colonial period, beginning in the eighteenth century, marked a turning point in Indian cannabis history. The British initially tolerated cannabis, recognizing its importance to Indian society and its value as a source of tax revenue. But as the temperance movement gained strength in Britain and as Western medical attitudes toward cannabis hardened, the British began to restrict its use. An 1894 commission, appointed to investigate cannabis use in India, produced a landmark report that concluded cannabis was not a significant cause of harm and should not be prohibited—a conclusion that the British government ignored, beginning a process of restriction that would culminate in prohibition after Indian independence.
The Indian cannabis tradition, with its deep roots in religion, medicine, and daily life, represents one of the longest continuous relationships between humans and a psychoactive plant in world history. That tradition survives today, though it has been transformed by modernization, globalization, and prohibition. In the sacred city of Varanasi, on the banks of the Ganges, sadhus still smoke chillums of ganja in honor of Shiva, and bhang shops still sell their preparations, legally under Indian law, to devotees and tourists alike. The ancient association of cannabis with the divine has not been forgotten, even as the plant has been demonized elsewhere in the world.
Chapter Six: Scythians, Persians, and the Steppe World
Between the great civilizations of China and India to the east and the Mediterranean world to the west lay the vast expanse of the Eurasian steppe, a belt of grassland stretching from Hungary to Mongolia. Here, for millennia, nomadic pastoralists herded horses, cattle, and sheep across a landscape that offered no fixed settlements but unlimited horizons. Among these peoples, cannabis occupied a central place, serving as a ritual substance, a medicinal aid, and a practical material for the tents, clothing, and equipment of nomadic life.
The Scythians, who dominated the western steppe from the seventh to the third centuries BCE, are the best-documented cannabis-using culture of the ancient steppe. Our knowledge of Scythian cannabis practices comes primarily from the Greek historian Herodotus, who described their purification rituals in his Histories, written in the fifth century BCE. According to Herodotus, when Scythian leaders died, they were embalmed and their bodies were transported to the royal burial grounds. The funeral involved the purification of the mourners, who would set up a small tent, place hemp seeds on red-hot stones, and crawl inside to inhale the resulting vapor. The Scythians, Herodotus wrote, "howled with joy" as they became intoxicated, and the experience was considered essential to the mourning process.
Herodotus's account, long regarded with skepticism by scholars, has been confirmed by archaeological discoveries. The frozen tombs of the Pazyryk culture, a Scythian-related people in the Altai Mountains, have yielded exactly the kind of tent and censer described by Herodotus, complete with cannabis residue. The Ice Maiden's tomb, discussed earlier, is one of several such burials that have been excavated, all containing evidence of cannabis use in mortuary contexts. The consistency of the finds across multiple tombs suggests that cannabis ritual was not merely occasional but central to Scythian religious practice.
The Scythians were not the only steppe people to use cannabis. The Sarmatians, who succeeded the Scythians in the western steppe, also used the plant, as did the Scythian-related peoples of Central Asia, such as the Sakas and the Massagetae. The practice of cannabis inhalation seems to have spread across the steppe as part of a common cultural complex, transmitted by the movement of peoples and the exchange of goods and ideas along the routes that would later become the Silk Road.
The role of cannabis in steppe cultures was not limited to ritual. The plant provided fiber for the felt tents, or yurts, in which the nomads lived, and for the ropes and cords that secured their pack animals. Cannabis seeds were an important food source, providing protein and oil that supplemented the diet of meat and dairy products. The practical uses of the plant were so important that some steppe cultures may have cultivated cannabis specifically for these purposes, though the mobile lifestyle of the nomads made agriculture difficult.
The Persian Empire, which emerged in the sixth century BCE and eventually incorporated much of the steppe into its territories, had its own traditions of cannabis use. The Zoroastrian religious tradition, which dominated Persia for centuries, viewed cannabis ambivalently. The Avesta, the Zoroastrian sacred text, mentions bhang as a substance that could induce intoxication, and it prescribes penalties for its use, suggesting that the priestly class disapproved of its consumption. However, Persian medical texts from later periods describe the therapeutic benefits of cannabis, and the plant was widely used in Persian medicine.
The Achaemenid Persian Empire (550-330 BCE), which stretched from India to the Balkans, was a crucible in which the cannabis traditions of the steppe, India, and the Middle East interacted. The empire's efficient road system and administrative apparatus facilitated the movement of goods and ideas, including knowledge about cannabis. Persian physicians and scholars translated Indian medical texts, incorporating Indian knowledge of cannabis into their own traditions, and Persian merchants carried cannabis products along the trade routes that connected the empire.
The steppe tradition of cannabis use would have a lasting influence on the cultures that emerged from it. The Mongol Empire, which conquered much of Eurasia in the thirteenth century CE, incorporated steppe cannabis traditions into its own practices, though the Mongols were more known for their use of fermented mare's milk than for cannabis. The Turkish peoples, who migrated from Central Asia to Anatolia and beyond, brought steppe cannabis traditions with them, contributing to the development of cannabis cultures in the Ottoman Empire and modern Turkey.
The archaeological evidence from the steppe also provides some of the earliest evidence for the psychoactive use of cannabis outside of Asia. The Scythian practice of cannabis inhalation may have influenced the Greek and Roman worlds, where cannabis was known but not widely used for psychoactive purposes. The Greek physician Dioscorides, writing in the first century CE, described the properties of cannabis but did not mention its intoxicating effects, suggesting that the Greek medical tradition was not yet familiar with the psychoactive potential of the plant. It would take centuries for knowledge of cannabis intoxication to spread from the steppe to the Mediterranean.
Chapter Seven: The Near East, Egypt, and the Ancient Mediterranean
The civilizations of the Near East and the Mediterranean had a different relationship with cannabis than their counterparts in Asia. They knew the plant, used it for fiber and medicine, but did not develop the rich psychoactive traditions that characterized China, India, and the steppe. The reasons for this difference are complex, involving climate, culture, and the availability of other intoxicants, but the result is that cannabis played a less prominent role in these civilizations than it did elsewhere.
The earliest evidence for cannabis in the Near East comes from archaeological sites in the Levant and Mesopotamia. At the site of Tel Arad in Israel, cannabis residue was found on a potteryshard dating to the eighth century BCE, and at the site of Tell es-Sultan (ancient Jericho), cannabis seeds have been recovered from contexts dating to the same period. These finds suggest that cannabis was present in the region but give no indication of how it was used.
The Assyrian Empire, which dominated Mesopotamia from the ninth to the seventh centuries BCE, left cuneiform tablets that mention cannabis in medical contexts. One tablet prescribes cannabis for the treatment of depression and impotence, while another describes its use in poultices for inflammation. The Assyrian medical tradition, which drew on earlier Sumerian and Babylonian knowledge, classified cannabis as a drug that could affect the spirit, but it did not emphasize its psychoactive properties.
The Egyptian evidence for cannabis is similarly limited but suggestive. The Ebers Papyrus, dating to 1550 BCE, is the oldest known Egyptian medical text, and it contains a reference to cannabis as a treatment for inflammation. The text prescribes the application of cannabis to the vagina to reduce swelling, suggesting that Egyptian physicians were familiar with the anti-inflammatory properties of the plant. Other Egyptian texts mention cannabis in the context of childbirth, where it was used to ease labor pains, and in the treatment of hemorrhoids.
The Egyptian use of cannabis has been the subject of considerable speculation, with some scholars claiming that it was used in religious rituals or as an intoxicant. The evidence for these claims is weak. The famous image of a cannabis plant on the wall of the Temple of Karnak, often cited as evidence of Egyptian cannabis cults, is probably a depiction of a different plant, and the chemical analyses of Egyptian mummies that have claimed to detect cannabis residues are methodologically questionable. The balance of evidence suggests that the Egyptians used cannabis primarily as a medicine and a source of fiber, not as a psychoactive substance.
The Greek and Roman worlds had a similar relationship with cannabis. The Greek historian Herodotus, as we have seen, described Scythian cannabis practices, but he did not indicate that Greeks used cannabis in the same way. The Greek physician Dioscorides, in his De Materia Medica, described two types of cannabis: a cultivated variety used for fiber and a wild variety that produced seeds for food. He noted that the seeds were useful for treating earaches and that the root could be applied to inflammations, but he did not mention psychoactive properties.
The Roman naturalist Pliny the Elder, writing in the first century CE, echoed Dioscorides in his Natural History. He described the use of hemp for rope and textiles, noting that it was stronger than flax, and he mentioned its medicinal applications. But like Dioscorides, he did not mention its intoxicating effects. The Roman physician Galen, writing in the second century CE, noted that hemp seeds were sometimes used to produce a sense of well-being when eaten, but he did not describe the intense intoxication associated with Indian cannabis.
The absence of psychoactive cannabis in Greco-Roman culture is striking given the extensive trade between the Mediterranean and Asia. The Greeks and Romans traded with India, Persia, and Central Asia, and they would certainly have encountered psychoactive cannabis in their commercial dealings. Yet they did not adopt it, perhaps because they already had their own intoxicants—wine above all—that filled the cultural niche that cannabis occupied elsewhere. Wine was central to Greek and Roman religion, social life, and medicine, and its cultural significance may have left little room for a competing intoxicant.
There were exceptions. The Greek historian Diodorus Siculus, writing in the first century BCE, described how the women of ancient Thebes used hemp to produce intoxicant, and the Roman author Apuleius, in his Golden Ass, mentioned hemp as a substance that could induce sleep. These scattered references suggest that psychoactive cannabis was known in the Mediterranean but was not widely used. The Greek and Roman worlds remained largely a non-cannabis culture, a fact that would have important consequences for the later history of the plant in Europe.
The early Christian church, emerging in the Roman world, inherited this ambivalent attitude toward cannabis. The Bible does not mention cannabis, and the early church fathers did not address its use. The Christian condemnation of intoxicants focused on wine, which was seen as a potential source of debauchery but also as a sacrament. Cannabis, being unfamiliar, was not a subject of theological debate. This would change only when cannabis became more widely known in Europe through contact with the Islamic world and through the colonial expansion of the European powers.
Part III: Cannabis in Religion, Spirituality, and Ritual
Chapter Eight: Bhang, Shiva, and the Hindu Tradition
The Hindu tradition of cannabis use is the oldest and most elaborate religious cannabis tradition in the world, with roots reaching back more than three thousand years. The association of cannabis with the god Shiva, the mythology of the plant's divine origin, and the elaborate rituals of bhang consumption have made cannabis an integral part of Hindu devotional practice for countless generations of believers.
The mythology of cannabis in Hinduism centers on the story of Shiva and the plant. According to the Shiva Purana, one of the foundational texts of Shaivism, Shiva was walking in the mountains after an argument with his wife Parvati when he came upon a patch of cannabis plants. He rested beneath them, and as the cooling shade of the leaves eased his anger, he began to eat them. The plant calmed his mind and lifted his spirits, and from that day forward, cannabis became his favorite food. The story explains why Shiva is often depicted with a cannabis pipe and why his followers consume cannabis as a sacrament: by eating the god's food, they enter into communion with him.
The mythology also credits cannabis with the power to confer enlightenment. One legend tells how Shiva, after consuming cannabis, entered a state of deep meditation that lasted for thousands of years. The plant's ability to quiet the mind and facilitate concentration made it the ideal tool for the ascetic practices that Shiva embodied. For his followers, consuming cannabis was not an escape from spiritual discipline but a means of deepening it, a way of entering into the altered states of consciousness that were necessary for spiritual progress.
The ritual use of cannabis in Hinduism takes many forms, but the most common is the consumption of bhang, a preparation made from the leaves and flowers of the cannabis plant ground with milk, sugar, and spices. Bhang is typically consumed during religious festivals, particularly Holi, the spring festival of colors, and Shivaratri, the night of Shiva. On these occasions, devotees gather at temples, where they are served bhang as a sacrament, and the consumption of the plant is understood as an act of devotion.
The preparation of bhang is itself a ritual process. The leaves and flowers are first washed to remove impurities, then ground with a mortar and pestle, often while reciting prayers or mantras. The ground material is mixed with milk, which draws out the psychoactive compounds, and then strained through cloth to remove the plant matter. The resulting liquid is flavored with spices—cardamom, ginger, fennel—and sweetened with sugar. The final product is a thick, greenish liquid that is served in small cups and consumed with reverence.
The bhang tradition is not limited to festivals. In many parts of India, particularly in the north, bhang shops operate legally under government license, selling the preparation to customers throughout the year. These shops, often located near temples, serve a clientele that includes sadhus (holy men), laborers, and ordinary people seeking relief from the heat or a mild euphoria. The legal status of bhang in India is an anomaly: cannabis in other forms—the dried flowers (ganja) and the resin (charas)—are prohibited, but the leaves and seeds used to make bhang are exempt under the country's drug laws.
The sadhu tradition has been particularly important in preserving Hindu cannabis culture. Sadhus are ascetic holy men who renounce worldly life in pursuit of spiritual liberation. Many sadhus, particularly those in the Shaiva tradition, consume cannabis as part of their daily practice, using it to quiet the mind and facilitate meditation. The sadhu's cannabis pipe, or chillum, is a sacred object, and the act of smoking is accompanied by prayers and offerings. The chillum is passed from hand to hand in a ritual that expresses the community of the sadhus and their devotion to Shiva.
The Hindu cannabis tradition has not been without its critics. Some Hindu reformers, influenced by Western attitudes toward drugs, have called for the prohibition of cannabis, arguing that it is incompatible with modern Hinduism. Others have pointed to the excesses of some sadhus and bhang drinkers as evidence of the dangers of cannabis use. But for the majority of Hindus who participate in the tradition, cannabis remains a legitimate sacrament, a gift from the gods that can be used responsibly in the proper context.
The survival of Hindu cannabis culture in the face of modern prohibition is a testament to its deep roots in Indian society. The British attempted to suppress bhang consumption in the nineteenth century, but they found it impossible to enforce prohibition against a practice so embedded in religion and daily life. The Indian government, after independence, maintained the British policy of tolerating bhang while prohibiting other forms of cannabis, a compromise that has allowed the tradition to continue.
Chapter Nine: Cannabis in Islam: Hashish, Poetry, and the Politics of Intoxication
The relationship between Islam and cannabis is one of the most complex and contested in the history of the plant. The Quran does not mention cannabis, and the hadith (sayings of the Prophet Muhammad) are ambiguous on the subject of intoxicants. This ambiguity has allowed for a wide range of interpretations, from total prohibition to cautious tolerance, and the history of cannabis in the Islamic world reflects this diversity.
The Islamic prohibition of wine, based on Quranic verses that condemn khamr (fermented grape juice), set the stage for debates about other intoxicants. The question was whether cannabis, which was not fermented, should be treated like wine or whether it belonged to a different category. Some Islamic jurists argued that all intoxicants were forbidden, regardless of their source, while others maintained that only those specifically mentioned in the Quran were prohibited. The debate continues to this day, with most Muslim-majority countries prohibiting cannabis but with significant variations in enforcement and punishment.
The earliest evidence for cannabis use in the Islamic world comes from the eighth and ninth centuries, when the Arab conquests brought the Islamic empire into contact with the cannabis-using cultures of Central Asia and India. The Abbasid Caliphate, which ruled from Baghdad from 750 to 1258, was a center of cultural and scientific exchange, and it was during this period that cannabis knowledge spread throughout the Islamic world. The caliphs and their courts experimented with cannabis, and poets composed verses in praise of its effects.
The most famous cannabis preparation to emerge from the Islamic world was hashish, a concentrated form of the plant's resin. Hashish was produced by sifting the dried cannabis flowers through a fine screen, separating the sticky trichomes from the plant matter, and pressing them into blocks. The result was a potent substance that could be smoked or eaten, producing effects far stronger than those of the raw plant. Hashish became particularly associated with the Sufi mystics, who used it as a tool for spiritual exploration and for inducing states of ecstatic union with the divine.
The Sufi tradition of cannabis use was one of the most sophisticated in the Islamic world. Sufis, seeking direct experience of God through altered states of consciousness, found in hashish a tool for bypassing the rational mind and accessing deeper levels of awareness. The consumption of hashish was often incorporated into Sufi rituals, with the drug used in combination with music, poetry, and dance to induce states of wadj (ecstasy). The great Persian poet Hafiz, writing in the fourteenth century, described the hashish experience in terms that blended the sensual and the spiritual, seeing in the drug a path to divine union.
The association of hashish with the Sufis gave it a certain legitimacy in Islamic culture, but it also made it a target for religious reformers. The orthodox ulema (religious scholars) viewed the Sufi use of hashish as a deviation from proper Islamic practice, and they condemned it as an innovation (bid'ah) that led believers astray. The conflict between the Sufis and the orthodox over hashish reflected deeper tensions in Islamic society between mystical and legalistic approaches to religion.
The political authorities in the Islamic world also had complex attitudes toward cannabis. Some rulers, like the Ottoman sultans, attempted to prohibit cannabis, seeing it as a threat to public order and military discipline. The Ottoman Empire imposed severe penalties for hashish use, including execution for repeat offenders, though these laws were often enforced unevenly. Other rulers, particularly in the Persian and Mughal empires, tolerated or even encouraged cannabis use, recognizing its importance to their subjects and its value as a source of tax revenue.
The European colonial powers, when they came to dominate the Islamic world in the nineteenth and twentieth centuries, brought with them their own attitudes toward cannabis. The British, French, and Dutch all attempted to restrict or prohibit cannabis in their colonies, often citing concerns about public health and social order. These efforts were resisted by local populations, who saw cannabis as an integral part of their culture and religion. The result was a protracted conflict between colonial authorities and indigenous cannabis traditions, a conflict that shaped the legal status of cannabis in the post-colonial period.
The modern Islamic world remains deeply divided on the issue of cannabis. Some countries, like Saudi Arabia and Iran, maintain strict prohibition with harsh penalties, including imprisonment and execution. Others, like Turkey and Lebanon, have more permissive policies, with cannabis cultivation tolerated in certain regions. In Morocco, the largest producer of hashish in the world, the government has moved toward legalization, recognizing that prohibition has failed to stop production and that the cannabis industry is a crucial part of the rural economy. These variations reflect the long and complex history of cannabis in the Islamic world, a history that continues to evolve.
Chapter Ten: Cannabis in African and Indigenous Traditions
The history of cannabis in Africa is as old as the history of the plant itself, though it has been less studied than the Asian or European traditions. Cannabis was introduced to Africa through trade routes that connected the continent to Asia and the Middle East, and it was adapted to local cultures in ways that produced distinctive traditions of use.
The earliest evidence for cannabis in Africa comes from the East African coast, where Arab and Persian traders introduced the plant as early as the ninth century CE. From the coast, cannabis spread inland along trade routes, reaching the Great Lakes region, Central Africa, and eventually southern Africa. By the fifteenth century, cannabis was being cultivated throughout much of the continent, and it had been integrated into local cultures and religious practices.
The most famous African cannabis tradition is that of the Rastafari movement in Jamaica, which combined African religious elements with Christian symbolism and a reverence for cannabis. But the Rastafari tradition is a relatively recent development, emerging in the 1930s, and it should not be confused with the older African traditions that preceded it. The cannabis cultures of Africa are diverse, reflecting the continent's linguistic, cultural, and ecological diversity.
In southern Africa, cannabis was known as dagga, a Khoisan word that has entered the vocabulary of several Bantu languages. The use of dagga was widespread among the Bantu-speaking peoples of the region, who used it in both medicinal and social contexts. The Zulu, Xhosa, Sotho, and other groups developed elaborate traditions of cannabis use, with the plant consumed in clay pipes, often in ritual contexts. The smoke was inhaled deeply and held for as long as possible, a practice that maximized the absorption of psychoactive compounds.
The role of cannabis in African traditional religion is complex and varies by region. In some societies, cannabis was used in rituals of divination, where the altered states it produced were believed to enable communication with ancestors and spirits. In others, it was used in healing ceremonies, where it was combined with other herbs and with music and dance to produce therapeutic trance states. In still others, it was used in initiation rituals, where it marked the transition from childhood to adulthood.
The colonial encounter transformed African cannabis traditions. European colonial authorities, influenced by the temperance movement and by racial stereotypes about drug use, attempted to suppress cannabis in their African colonies. The British, French, Portuguese, and Belgians all enacted prohibition laws, though they were often unable to enforce them effectively. The result was the criminalization of practices that had been integral to African cultures for centuries, creating tensions that persist to the present day.
The post-colonial period has seen a complex evolution of African cannabis policy. Some countries, like South Africa, have moved toward decriminalization, with a 2018 Constitutional Court ruling that personal use of cannabis is a private matter not subject to criminal sanction. Others, like Nigeria and Kenya, maintain strict prohibition, though enforcement is often uneven and corruption is widespread. The cannabis trade is a major part of the informal economy in many African countries, providing income for millions of small-scale farmers and creating complex networks of production and distribution.
The indigenous traditions of the Americas, by contrast, had no cannabis before European contact. The plant is not native to the Americas, and it was introduced by Europeans in the colonial period. However, indigenous peoples in the Americas adapted the plant to their own traditions, creating new forms of cannabis use that combined indigenous and European elements. In Mexico, indigenous groups incorporated cannabis into traditional healing practices, and in the United States, Native American tribes have used cannabis in religious ceremonies, sometimes as a substitute for traditional psychoactive plants that have become scarce.
The history of cannabis in Africa and among indigenous peoples around the world is a reminder that the plant's uses are not fixed but are constantly being reinvented. Cannabis has shown a remarkable capacity to adapt to new cultural contexts, taking on new meanings and uses as it moves from one society to another. This adaptability is one of the reasons for its global spread and for its enduring significance in human cultures.
Chapter Eleven: Cannabis in East Asian Religions: Daoism, Buddhism, and Shinto
The religious traditions of East Asia had a complex relationship with cannabis, reflecting the region's long history of interaction with the plant. In China, Daoism incorporated cannabis into its practices of seeking immortality, while Buddhism, which entered China from India, brought Indian traditions of cannabis use that were adapted to Chinese contexts. In Japan, Shinto rituals incorporated hemp as a purifying agent, and the plant was considered sacred in some traditions.
The Daoist tradition, which emerged in China in the early centuries CE, was particularly important for the religious use of cannabis. Daoist practitioners sought to achieve immortality through a combination of meditation, breathing exercises, sexual practices, and the consumption of herbal elixirs. Cannabis was one of the herbs used in these elixirs, and it was believed to facilitate communication with the spirits and to enable the practitioner to ascend to the heavens. The Daoist master Ge Hong, writing in the fourth century CE, described how the consumption of cannabis could produce visions and enable the practitioner to see spirits.
The Daoist use of cannabis was not without its dangers. Ge Hong warned that excessive consumption could lead to madness, and he recommended that it be used only under the guidance of a qualified master. The Daoist tradition also developed techniques for using cannabis in combination with other substances, creating formulas that were believed to balance the plant's effects and minimize its harms. These formulas, which often included herbs like ginseng and reishi mushroom, were part of a broader Daoist pharmacopoeia of longevity.
Buddhism's relationship with cannabis was more ambivalent. The early Buddhist monastic codes, the Vinaya, prohibited the use of intoxicants, including cannabis, for monks and nuns. This prohibition was based on the fifth precept, which forbade the consumption of substances that cloud the mind. However, the precept was interpreted differently in different Buddhist traditions, and lay practitioners were generally not bound by it. In some Buddhist cultures, particularly in Tibet and the Himalayas, cannabis was used in Tantric rituals, where it was seen as a tool for transforming the mind and achieving enlightenment.
The Chan (Zen) tradition, which emerged in China in the sixth century CE, had a particularly complex relationship with cannabis. Chan monks practiced meditation as a path to enlightenment, and some Chan masters permitted the use of cannabis as an aid to meditation, arguing that it could quiet the mind and facilitate concentration. Other Chan masters opposed its use, seeing it as a crutch that interfered with genuine spiritual development. The debate within Chan Buddhism over cannabis reflected the broader tensions within the tradition between those who emphasized strict discipline and those who emphasized intuitive awakening.
In Japan, the Shinto tradition incorporated cannabis into its purification rituals. Hemp was considered a sacred plant, capable of purifying the body and spirit, and it was used in ceremonies to mark important life events, including birth, marriage, and death. The tamagushi, a branch of the sacred sakaki tree used in Shinto offerings, was sometimes tied with hemp cord, and hemp fibers were used in the construction of the shimenawa, the sacred ropes that mark the boundaries of Shinto shrines. The association of hemp with purity and sanctity in Shinto has persisted to the present day, even as cannabis has been prohibited in other contexts.
The religious use of cannabis in East Asia has declined dramatically in the modern era, as prohibition has made the plant illegal and as traditional religious practices have been disrupted by modernization. However, vestiges of these traditions survive. In China, some Daoist practitioners continue to use cannabis in their rituals, though they must do so discreetly to avoid legal consequences. In Japan, the sacred use of hemp fibers in Shinto ceremonies continues, though the cannabis used for this purpose is grown under government license. And in the Himalayas, Buddhist monks in some traditions continue to use cannabis as a ritual substance, maintaining a practice that dates back more than a thousand years.
Part IV: Medieval and Early Modern Worlds
Chapter Twelve: The Islamic Golden Age: Medicine, Science, and Hashish Culture
The Islamic Golden Age, from the eighth to the thirteenth centuries, was a period of remarkable scientific and cultural achievement, and cannabis played a significant role in it. Islamic scholars translated Greek, Persian, and Indian medical texts, synthesized their knowledge, and added their own observations, creating a medical tradition that was the most advanced in the world. Cannabis was part of this tradition, and the Islamic world developed sophisticated understandings of its medicinal properties and its potential for harm.
The Islamic medical tradition, building on Greek and Persian foundations, classified cannabis as a drug with both therapeutic and toxic properties. The great Persian physician Avicenna (Ibn Sina), writing in the eleventh century, described cannabis in his Canon of Medicine, which became the standard medical text in Europe as well as the Islamic world for centuries. Avicenna noted that cannabis could relieve pain, reduce inflammation, and induce sleep, but he also warned that excessive consumption could cause confusion, dizziness, and impotence. His balanced assessment, which recognized both the benefits and the risks of the plant, was characteristic of Islamic medical thinking.
Islamic physicians also developed sophisticated preparations of cannabis for medical use. The leaves and seeds were used in poultices and plasters for external application, while extracts were prepared for internal consumption. The resin, known as hashish, was used in small doses as a sedative and pain reliever, though its potency meant that it required careful dosing. Islamic physicians were also aware of the variability in cannabis potency, noting that the plants from different regions had different effects and that the time of harvest affected the strength of the medicine.
The cultural status of hashish in the Islamic world was complex. On one hand, it was associated with the mystical traditions of Sufism, where it was used as a tool for spiritual exploration. On the other hand, it was associated with the lower classes, who used it as an escape from poverty and hardship. The tension between these associations played out in the legal and literary debates of the period. Some Islamic scholars defended the use of hashish, arguing that it was not prohibited by the Quran, while others condemned it, seeing it as a threat to morality and social order.
The literary tradition of hashish in the Islamic world was rich and varied. Poets composed verses in praise of the drug, describing its effects in terms that blended the sensual and the spiritual. The thirteenth-century Persian poet Rumi, founder of the Mevlevi order of Sufis, wrote of hashish as a door to the divine, a substance that could dissolve the ego and open the heart to God. Other poets were more critical, describing the degradation and poverty that hashish use could cause. The debate in literature reflected the broader cultural ambivalence about the drug.
The political authorities in the Islamic world had varying attitudes toward hashish. The Fatimid caliphs of Egypt, who ruled from the tenth to the twelfth centuries, were known to tolerate hashish use, and the drug was widely available in Cairo and other cities. The Mamluks, who succeeded the Fatimids, took a harder line, imposing penalties for hashish use and attempting to suppress the trade. The Ottoman sultans, who ruled much of the Islamic world from the fourteenth to the twentieth centuries, also attempted to prohibit hashish, though they were never fully successful in eradicating it.
The European encounter with hashish came through the Crusades and through trade with the Islamic world. European travelers to the Middle East brought back stories of hashish use, often exaggerating its effects and portraying it as a dangerous vice. The legend of the "Old Man of the Mountain" and the Assassins, a sect of Nizari Ismailis who were said to use hashish to control their followers, became part of European folklore, though the historical accuracy of these accounts is questionable. The association of hashish with violence and moral corruption would persist in European attitudes for centuries.
The Islamic Golden Age also saw the development of sophisticated theories about the nature of intoxication and its effects on the human soul. Islamic philosophers and theologians debated whether altered states of consciousness could provide genuine insights into the nature of reality or whether they were merely illusions. Some argued that hashish, like wine, could lower the barriers of the rational mind and allow access to deeper truths, while others maintained that any substance that altered consciousness was a form of deception. These debates anticipated the philosophical questions that would later arise about psychedelic drugs in the West.
Chapter Thirteen: Medieval Europe: Hemp, Heresy, and the Fear of Witches
Medieval Europe had a different relationship with cannabis than the Islamic world. Hemp was cultivated widely for fiber, providing the rope, cordage, and sailcloth that made maritime trade and naval warfare possible. But psychoactive cannabis was little known, and when it was known, it was often associated with heresy, witchcraft, and the forces of evil.
The cultivation of hemp in medieval Europe was centered in regions with cool, moist summers, particularly in Italy, France, and the Low Countries. Hemp was an important cash crop, and its cultivation was regulated by feudal lords and municipal authorities. The fibers were used for rope, sailcloth, and coarse textiles, while the seeds were used for oil and animal feed. Hemp was also used for paper, and the first paper mills in Europe, established in the twelfth century, used hemp fiber as their raw material.
The economic importance of hemp in medieval Europe cannot be overstated. The maritime economies of Venice, Genoa, and the Hanseatic League depended on hemp for their ships' rigging and sails. The wool trade of England and Flanders required hemp for the sacks in which wool was transported. And the clothing of peasants and laborers was often made from hemp, which was cheaper than wool or linen. Hemp was, in short, a material that underpinned the medieval economy.
Despite its economic importance, hemp had a low cultural status in medieval Europe. It was associated with the lower classes, with peasants and laborers who wore hemp clothing and used hemp ropes. The plant was also associated with the devil in some traditions, perhaps because of its psychoactive properties, which were known but not widely understood. The idea that witches used hemp in their potions appears in some medieval texts, and the plant was sometimes included in lists of magical herbs.
The Inquisition, which targeted heretics and witches in the late medieval and early modern periods, took an interest in cannabis. Some of the confessions extracted from accused witches included references to the use of hemp ointments and potions, though it is difficult to separate fact from fantasy in these accounts. The association of cannabis with witchcraft may have contributed to the plant's negative reputation in Europe, a reputation that would persist into the modern era.
The introduction of psychoactive cannabis to Europe came through two main channels: trade with the Islamic world and the colonization of the Americas. European merchants who traded with the Ottoman Empire encountered hashish in the cities of the eastern Mediterranean, and some brought it back to Europe. The use of hashish among European intellectuals and artists began in the eighteenth century, but it remained a niche practice until the nineteenth century, when the Romantic movement's interest in altered states of consciousness brought cannabis into wider currency.
The medieval European experience with cannabis thus set the stage for the modern era. Hemp was a familiar and economically essential plant, but psychoactive cannabis was foreign, exotic, and associated with the enemies of Christendom. This ambivalent inheritance—familiarity with the plant combined with suspicion of its psychoactive properties—would shape European attitudes toward cannabis for centuries to come.
Part V: Colonialism, Migration, and Global Spread
Chapter Fourteen: Hemp and Empires: The Making of a Strategic Commodity
The early modern period saw the expansion of European empires across the globe, and hemp was central to this expansion. The maritime empires of Spain, Portugal, England, France, and the Netherlands depended on hemp for their ships' rigging and sails, and the control of hemp supplies became a strategic imperative for these powers. The quest for hemp led to the establishment of colonial plantations, the development of new trade routes, and the creation of policies that shaped the global cannabis economy for centuries.
The Spanish Empire, which controlled much of the Americas, attempted to establish hemp cultivation in its colonies to supply its navy. The Spanish crown offered subsidies and land grants to farmers who would grow hemp, but the plant never became a major crop in the Spanish colonies, perhaps because the climate was not suitable or because farmers preferred more profitable crops. The English, by contrast, had more success in establishing hemp cultivation in their North American colonies, where the climate of Virginia and Kentucky proved ideal for the plant.
The British Navy was the largest consumer of hemp in the world in the eighteenth and nineteenth centuries, and the security of its hemp supply was a matter of national security. The British relied primarily on hemp from the Baltic region, particularly from Russia, where the plant was grown extensively. But the British also encouraged hemp cultivation in their colonies, offering bounties to farmers who would grow the plant and imposing tariffs on imported hemp to protect domestic producers.
The American colonies were an important source of hemp for the British Empire, and the plant became a major cash crop in Virginia, Maryland, and Kentucky. George Washington grew hemp at Mount Vernon, and Thomas Jefferson experimented with hemp cultivation at Monticello. Both men believed that hemp could be a source of wealth for the new nation, and they advocated for policies to support its cultivation. The Declaration of Independence was drafted on hemp paper, a fact that is sometimes cited as evidence of the plant's importance in early American history.
The Industrial Revolution transformed the hemp industry. The invention of the cotton gin in 1793 made cotton cheaper and more widely available, displacing hemp as a textile fiber. The development of synthetic fibers in the nineteenth and twentieth centuries further reduced the demand for hemp. But hemp remained important for certain applications, particularly for rope and sailcloth, where its strength and durability could not be matched by other materials.
The maritime hemp trade also had a dark side. The labor that produced hemp in the Baltic and in the American colonies was often coerced. In Russia, hemp cultivation was based on serf labor, with peasants required to devote a portion of their land and time to growing hemp for the state. In the American South, hemp was grown by enslaved Africans, who were forced to cultivate and process the plant under brutal conditions. The history of hemp is thus entangled with the history of slavery and serfdom, a connection that is often overlooked in celebrations of the plant's industrial virtues.
The decline of the sailing navy in the late nineteenth century, as steam power replaced wind power, reduced the demand for hemp for maritime uses. The steel-hulled ships that replaced wooden sailing vessels required less rope and no sailcloth, and the hemp industry went into a decline from which it never fully recovered. By the early twentieth century, hemp had been reduced from a strategic commodity to a minor agricultural product, grown only in regions where it was particularly well suited to local conditions.
The revival of hemp in the late twentieth and early twenty-first centuries, driven by environmental concerns and the legalization of cannabis, has attempted to recapture some of the plant's former glory. Hemp is now grown for a variety of purposes, including textiles, building materials, bioplastics, and biofuels, and it is seen by some as a sustainable alternative to resource-intensive crops. But the scale of modern hemp production is a fraction of what it was in the eighteenth century, and it remains to be seen whether the plant can regain its former importance in the global economy.
Chapter Fifteen: The African Diaspora and Cannabis in the Caribbean
The transatlantic slave trade brought millions of Africans to the Americas, and with them came African traditions of cannabis use. The slaves carried seeds from their homelands, and they cultivated cannabis in the Caribbean and the Americas, using it in ways that preserved African practices while adapting to new conditions. The result was the creation of distinctive Afro-Caribbean cannabis cultures that would later influence the global spread of the plant.
The earliest evidence for cannabis in the Caribbean comes from the seventeenth century, when slaves from West Africa, where cannabis had been cultivated for centuries, brought the plant to the islands. The British colony of Jamaica became a particular center of cannabis culture, with the plant becoming known as ganja, a word of Hindi origin that had been introduced to the Caribbean through the indenture system. The association of ganja with African and Indian laborers gave the plant a subaltern status, associated with the lower classes and with resistance to colonial authority.
The use of cannabis in the Caribbean was initially concentrated among the enslaved and indentured populations, who used it for both medicinal and recreational purposes. The plant was valued for its ability to relieve the pain and fatigue of labor, to provide comfort in the face of oppression, and to create spaces of community and solidarity. The colonial authorities viewed this use with suspicion, and they attempted to suppress it through laws and punishments. But the plant proved resilient, and the traditions of cannabis use survived.
The most famous Caribbean cannabis tradition is that of the Rastafari movement, which emerged in Jamaica in the 1930s. Rastafari combined African religious elements, Christian symbolism, and a reverence for cannabis that was rooted in both African and Indian traditions. For Rastafari, cannabis, or ganja, is a sacrament, a means of achieving spiritual insight and connecting with the divine. The Rastafari interpretation of cannabis was influenced by the biblical passage in which God says, "I have given you every herb bearing seed," which Rastafari interpret as a divine endorsement of cannabis use.
The Rastafari movement brought cannabis to global attention in the 1960s and 1970s, through the music of Bob Marley and other reggae artists. Marley's songs, which celebrated ganja as a sacrament and a tool of liberation, introduced cannabis to audiences around the world and helped to create the association of cannabis with rebellion and countercultural values. The image of Rastafari smoking ganja in the hills of Jamaica became a powerful symbol of resistance to oppression and a celebration of African identity.
The influence of Caribbean cannabis traditions extended beyond Rastafari. The development of the modern cannabis trade in the United States was shaped by Caribbean connections, with Jamaican and other Caribbean immigrants playing a role in the introduction of cannabis to American cities. The cultural practices associated with cannabis—the language, the music, the style—were influenced by Caribbean traditions, and the plant's association with Caribbean culture contributed to its exotic appeal.
The history of cannabis in the Caribbean is also a history of prohibition and resistance. The colonial authorities attempted to suppress cannabis use from the earliest days, and the independent Caribbean states continued these policies after independence. But the enforcement of prohibition has been uneven, and the cannabis trade has become a major part of the informal economy in many Caribbean countries. In recent years, some Caribbean nations have moved toward decriminalization or legalization, recognizing that prohibition has failed and that the cannabis industry could provide economic benefits.
Chapter Sixteen: Mexico, Latin America, and the Birth of Marihuana
The history of cannabis in Latin America is closely tied to the history of Spanish colonization. The Spanish introduced hemp to their American colonies in the sixteenth century, hoping to establish a domestic source of fiber for their maritime and textile industries. The plant adapted well to the climate of Mexico, Colombia, and other regions, and it became naturalized in many areas, growing as a weed along roadsides and in fields.
The use of cannabis as a psychoactive substance in Latin America began with the African slaves who were brought to the region. The slaves brought cannabis seeds from Africa, and they cultivated the plant for use in their own communities. The plant also became associated with indigenous peoples, who incorporated it into their traditional healing practices. By the eighteenth century, cannabis was being used across much of Latin America, though it remained a marginalized practice, associated with the lower classes and with people of color.
The word marihuana (or marijuana) appears to have originated in Mexico in the nineteenth century, though its etymology is uncertain. Some scholars trace it to a Chinese word, ma ren hua, meaning "hemp flower," while others suggest it comes from the Spanish Maria Juana (Mary Jane), a slang term that may have been used to disguise the reference. Whatever its origin, the word became the standard term for cannabis in Mexico and, later, in the United States, where it was adopted by the anti-cannabis movement to emphasize the plant's foreign and dangerous character.
The Mexican Revolution (1910-1920) was a turning point in the history of cannabis in Latin America. The revolution displaced millions of people, and many Mexicans migrated to the United States, bringing with them their traditions of cannabis use. The influx of Mexican immigrants into the American Southwest introduced cannabis to a new audience, and it also provoked a reaction from American authorities, who associated the plant with the immigrants and with the social problems of the border region.
The American campaign against cannabis, which gained momentum in the 1920s and 1930s, was explicitly linked to anti-Mexican sentiment. Harry Anslinger, the head of the Federal Bureau of Narcotics, promoted the idea that cannabis was a "killer weed" that caused violence, madness, and crime, and he linked it to Mexican immigrants, African Americans, and other marginalized groups. The racialized campaign against cannabis succeeded in creating a moral panic that led to the passage of the Marihuana Tax Act of 1937, which effectively prohibited cannabis in the United States.
The Mexican government, under pressure from the United States, also enacted prohibition laws, and cannabis became illegal in Mexico in 1920. But prohibition did not end cannabis use in Mexico; it merely drove it underground. The country became a major producer of cannabis for the American market, and the illegal trade created powerful criminal organizations that would later become the drug cartels that have plagued Mexico for decades.
The history of cannabis in Latin America is not limited to Mexico. Colombia, Jamaica, Paraguay, and other countries also became major producers, supplying cannabis to markets in North America and Europe. The illegal trade created economic opportunities for poor farmers but also brought violence, corruption, and political instability. The United States, as the largest consumer market, exerted enormous influence over drug policies in Latin America, pressuring governments to enforce prohibition and to cooperate with American efforts to interdict the drug trade.
In recent years, some Latin American countries have begun to reconsider their cannabis policies. Mexico legalized medical cannabis in 2017 and has moved toward adult-use legalization. Colombia, Uruguay, and other countries have also liberalized their laws, recognizing that prohibition has failed to reduce consumption and has caused enormous harm. The shift in policy reflects a growing recognition that the war on drugs has been a failure and that new approaches are needed.
Chapter Seventeen: Southeast Asia: Cannabis and the Colonial Encounter
Southeast Asia has a long history of cannabis use, dating back to the early migrations of Austronesian peoples who brought the plant from the Asian mainland. The region's tropical climate proved ideal for cannabis cultivation, and the plant became integrated into local cultures, used for medicine, ritual, and recreation. The history of cannabis in Southeast Asia is also closely tied to the history of opium, with the two drugs often being used in combination and regulated by the same authorities.
The earliest evidence for cannabis in Southeast Asia comes from archaeological sites in Thailand and Vietnam, where hemp fibers have been found in pottery dating to the Neolithic period. The plant was used for fiber and for its seeds, which were eaten as food. The psychoactive properties of cannabis were also known, and the plant was used in traditional medicine and in rituals associated with the indigenous religions of the region.
The introduction of Indian and Chinese cultures to Southeast Asia brought new cannabis traditions. Indian traders and settlers brought the bhang and ganja traditions of South Asia, and Chinese immigrants brought their own traditions of hemp cultivation and medicinal use. The result was a syncretic cannabis culture that combined elements from multiple sources, creating distinctive local practices.
The colonial period transformed cannabis in Southeast Asia. The British, French, and Dutch established colonial regimes that regulated the drug trade, often for their own benefit. The British, who controlled India and Burma, maintained a monopoly on opium production and trade, and they also regulated cannabis, though less strictly. The French, in Indochina, allowed cannabis use to continue, recognizing that it was deeply embedded in local cultures. The Dutch, in Indonesia, took a harder line, attempting to suppress cannabis use in the interests of public order.
The Vietnam War era brought Southeast Asian cannabis to global attention. American soldiers stationed in Vietnam, Thailand, and other countries encountered potent cannabis varieties, known as Thai sticks or Cambodian red, that were far stronger than the Mexican or American varieties they had known at home. The soldiers brought these varieties back to the United States, introducing new genetics that would transform the American cannabis market. The war also disrupted the region's cannabis economy, as the conflict made cultivation and trade dangerous.
The post-war period has seen Southeast Asia become a major producer of cannabis for the global market. Thailand, Cambodia, Laos, and Vietnam have all been significant sources of the plant, though the trade has been disrupted by the region's complex politics and by the pressures of international drug control. In recent years, some Southeast Asian countries have begun to liberalize their cannabis laws. Thailand legalized medical cannabis in 2018, becoming the first Southeast Asian nation to do so, and other countries are considering similar moves.
The history of cannabis in Southeast Asia is also a history of the plant's role in resistance and rebellion. In Thailand, cannabis was associated with peasant movements and with opposition to military rule. In the Philippines, the communist insurgency funded itself in part through the cannabis trade. And across the region, cannabis has been used by marginalized groups as a source of income and as a symbol of resistance to authority.
Part VI: Nineteenth‑Century Medicine and Science
Chapter Eighteen: Cannabis in Western Medicine: From Curiosity to Cure
The nineteenth century was a period of remarkable change in Western attitudes toward cannabis. The plant, which had been little used in Europe for psychoactive purposes, became a subject of intense medical interest, as physicians and scientists explored its therapeutic potential. The result was a flowering of cannabis medicine that produced hundreds of scientific papers, dozens of pharmaceutical preparations, and a body of clinical experience that would later be rediscovered in the modern medical cannabis movement.
The entry of cannabis into Western medicine was facilitated by the work of William Brooke O'Shaughnessy, an Irish physician working in India in the 1830s. O'Shaughnessy, who was interested in the medicinal properties of Indian drugs, experimented with cannabis and found it to be an effective treatment for a range of conditions, including pain, muscle spasms, and the convulsions of rabies and tetanus. He published his findings in 1839, and his paper introduced cannabis to the Western medical community.
O'Shaughnessy's work was followed by a wave of research in Europe and America. French physicians, including the psychiatrist Jacques-Joseph Moreau de Tours, explored the effects of cannabis on the mind, finding that it could induce states of euphoria, altered perception, and delirium. Moreau, who experimented with hashish on himself and his patients, believed that the drug could be used to study the mechanisms of mental illness, and he argued that it could be a useful treatment for some psychiatric conditions.
The American physician E.R. Squibb, founder of the pharmaceutical company that bears his name, developed methods for standardizing cannabis extracts, making it possible to produce preparations of consistent potency. Squibb's work was important because the variability of cannabis potency had been a major obstacle to its medical use. By standardizing the extracts, Squibb made it possible for physicians to prescribe cannabis with confidence in the dose and effect.
By the mid-nineteenth century, cannabis was a standard medicine in Western pharmacopoeias. It was included in the United States Pharmacopoeia in 1850 and remained there until 1942. It was prescribed for a wide range of conditions, including pain, inflammation, insomnia, anxiety, and loss of appetite. It was also used as a treatment for the withdrawal symptoms of opium addiction, and it was sometimes prescribed for the pain of childbirth.
The cannabis medicines of the nineteenth century took various forms. Tinctures, made by soaking cannabis in alcohol, were the most common preparation. These could be taken orally, and the dose could be adjusted by the number of drops. Cannabis was also available as an extract, a resin, and a smoking preparation. Some pharmaceutical companies sold cannabis cigarettes, which were marketed for asthma and other respiratory conditions.
The medical literature of the period is filled with case reports and clinical studies of cannabis. Physicians described its effects in glowing terms, praising its ability to relieve pain, calm the mind, and restore appetite. Some physicians warned of its potential for abuse, but most believed that it could be used safely under medical supervision. The attitude was one of cautious optimism, with the benefits seen as outweighing the risks.
The limitations of nineteenth-century medicine also constrained the use of cannabis. The lack of standardization in preparations meant that the potency of cannabis medicines varied widely, leading to inconsistent effects. The absence of reliable methods for administering the drug—smoking was seen as crude, and oral preparations had unpredictable absorption—made it difficult for physicians to achieve consistent results. And the competition from new synthetic drugs, particularly aspirin and barbiturates, began to erode cannabis's place in the pharmacopoeia.
By the end of the nineteenth century, the enthusiasm for cannabis in Western medicine was beginning to wane. The rise of the temperance movement, which associated all intoxicants with moral decay, contributed to a more negative view of cannabis. The increasing regulation of drugs, both at the national and international levels, made it more difficult for physicians to obtain and prescribe cannabis. And the growing association of cannabis with marginalized groups—Mexicans in the American Southwest, African Americans in the cities, and bohemians in Europe—made it less acceptable to the medical establishment.
Chapter Nineteen: The Discovery of Cannabinoids and the Endocannabinoid System
The scientific study of cannabis entered a new phase in the twentieth century, as advances in chemistry and pharmacology made it possible to isolate and characterize the plant's active compounds. The discovery of THC, CBD, and other cannabinoids, and the later discovery of the endocannabinoid system, transformed the scientific understanding of how cannabis works and opened new avenues for drug development.
The first step in this scientific revolution came in the 1940s, when researchers in the United States and Europe began to isolate the active compounds in cannabis. The British chemist Robert Cahn identified the structure of cannabinoid in 1940, and the American chemist Roger Adams isolated cannabidiol (CBD) in 1942. But it was not until 1964 that the Israeli chemist Raphael Mechoulam and his colleagues isolated and synthesized delta-9-tetrahydrocannabinol (THC), the primary psychoactive compound in cannabis.
Mechoulam's discovery was a breakthrough. By isolating THC, he made it possible to study its effects in pure form, without the confounding influence of other compounds in the plant. He also developed methods for synthesizing THC, making it available for research in large quantities. Mechoulam's work laid the foundation for the modern scientific study of cannabis, and he is often called the father of cannabis research.
The discovery of THC was followed by the discovery of other cannabinoids, including cannabigerol (CBG), cannabichromene (CBC), and tetrahydrocannabivarin (THCV). Each of these compounds has its own pharmacological profile, and the ratios among them determine the effects of different cannabis varieties. The understanding of these compounds has made it possible to develop cannabis varieties with specific therapeutic properties, such as high-CBD strains that produce minimal psychoactive effects.
The next major breakthrough came in the 1990s, with the discovery of the endocannabinoid system. Researchers working in Mechoulam's laboratory and elsewhere identified the receptors that THC binds to in the brain, known as CB1 receptors, and later identified a second receptor, CB2, found primarily in the immune system. They also discovered the endogenous compounds that bind to these receptors—anandamide (from the Sanskrit ananda, meaning bliss) and 2-arachidonoylglycerol (2-AG)—and the enzymes that synthesize and break them down.
The discovery of the endocannabinoid system revolutionized the scientific understanding of cannabis. It showed that the plant's effects are not accidental but are mediated by a system that is fundamental to human biology. The endocannabinoid system regulates mood, appetite, pain sensation, memory, and immune function, and it is involved in a wide range of physiological processes. The existence of this system explains why cannabis has such diverse effects and why it has been used for so many purposes across cultures and millennia.
The discovery of the endocannabinoid system also opened new avenues for drug development. By targeting this system, researchers have developed drugs that can modulate its activity without the psychoactive effects of THC. The most successful of these is Epidiolex, a CBD-based drug that has been approved for the treatment of certain forms of epilepsy. Other drugs that target the endocannabinoid system are in development for conditions including pain, obesity, and inflammatory diseases.
The scientific study of cannabis has also revealed the mechanisms of cannabis's potential harms. THC's effects on the developing brain, particularly in adolescents, have been documented, and the drug's potential to induce psychosis in vulnerable individuals has been studied. The respiratory effects of smoking cannabis have been investigated, and the risks of cannabis use disorder, a form of addiction, have been characterized. The scientific understanding of these harms has informed public health policies and has shaped the debate over legalization.
The scientific study of cannabis is far from complete. The plant contains more than one hundred cannabinoids, most of which have not been studied in depth. The interactions between cannabinoids and terpenes—the aromatic compounds that give cannabis its distinctive smell—are only beginning to be understood. And the long-term effects of cannabis use, particularly in the context of high-potency modern varieties, are still being investigated. The scientific revolution that began with the isolation of THC is still unfolding, and it promises to deepen our understanding of cannabis for years to come.
Chapter Twenty: The Medical Cannabis Movement: From Underground to Mainstream
The medical cannabis movement emerged in the 1970s and 1980s, as patients and activists began to challenge the prohibition of a plant that they believed could relieve their suffering. The movement grew out of the counterculture of the 1960s, but it was driven by a new set of concerns: the needs of people with AIDS, cancer, and other serious illnesses who found that cannabis could alleviate their symptoms when conventional medicine failed.
The turning point for the medical cannabis movement was the AIDS crisis of the 1980s. People with AIDS experienced severe weight loss, nausea, and pain, and many found that cannabis could relieve these symptoms, improving their appetite and quality of life. The federal government, which maintained that cannabis had no medical value, refused to allow patients to use it, and the Food and Drug Administration (FDA) made it difficult to conduct research on the drug.
In response, patients and activists began to organize. The San Francisco Cannabis Buyers Club, founded in 1991 by Dennis Peron, was the first public cannabis dispensary in the United States, providing cannabis to people with AIDS and other illnesses. The club operated in defiance of federal law, but it was tolerated by local authorities, who saw the need for the service. The model of the dispensary, which provided cannabis to patients in a regulated setting, would become the template for medical cannabis programs across the country.
The state-level movement for medical cannabis began in California, where voters passed Proposition 215 in 1996, making California the first state to legalize medical cannabis. The initiative, which was supported by a coalition of AIDS activists, cancer patients, and libertarians, allowed patients with a doctor's recommendation to possess and cultivate cannabis for medical use. The federal government opposed the measure, but it was implemented nonetheless, and other states soon followed.
The medical cannabis movement spread across the United States in the following decades. By 2024, more than thirty states had legalized medical cannabis, and the programs varied widely in their scope and structure. Some states, like California and Colorado, had relatively permissive programs that allowed for a wide range of conditions and for the operation of commercial dispensaries. Others, like New York and Illinois, had more restrictive programs that limited access and tightly regulated the industry.
The medical cannabis movement also spread internationally. Canada legalized medical cannabis in 2001, and the country's program became a model for other nations. Israel, which had been a leader in cannabis research since the 1960s, legalized medical cannabis in the 1990s, and the country has become a major producer of medical cannabis for the global market. Germany, the United Kingdom, Australia, and other countries have also established medical cannabis programs, though they vary widely in their accessibility and scope.
The medical cannabis movement has been driven by patient advocacy and by a growing body of scientific evidence supporting the therapeutic use of cannabis. Studies have shown that cannabis can be effective for chronic pain, nausea and vomiting from chemotherapy, muscle spasticity from multiple sclerosis, and other conditions. The evidence is strongest for these indications, and the FDA has approved several cannabis-based drugs for these uses. The evidence for other indications, such as anxiety, depression, and post-traumatic stress disorder, is less robust, but it is growing.
The medical cannabis movement has also faced challenges. The federal prohibition of cannabis in the United States has made it difficult for patients to access the drug, for researchers to study it, and for businesses to operate in the industry. The banking system, which is federally regulated, has been largely closed to the cannabis industry, forcing businesses to operate in cash and creating security risks. And the tension between state and federal law has created legal uncertainty that has hampered the industry's growth.
Despite these challenges, the medical cannabis movement has succeeded in changing public attitudes toward cannabis. The idea that cannabis has medical value, which was once dismissed by the federal government as a myth, is now widely accepted. The movement has also laid the groundwork for the legalization of adult-use cannabis, which has followed a similar trajectory of state-level reform and shifting public opinion.
Part VII: Prohibition and the Making of Modern Cannabis Law
Chapter Twenty‑One: The Making of Prohibition: Race, Fear, and the Marihuana Tax Act
The prohibition of cannabis in the United States was not the inevitable result of scientific evidence or public health concerns but was the product of a concerted campaign by law enforcement officials, moral entrepreneurs, and politicians who used the plant as a symbol of the dangers of immigration, racial mixing, and social change. The campaign against "marihuana" in the 1930s created the template for drug prohibition that would be exported around the world, and its legacy continues to shape cannabis policy today.
The federal government's interest in cannabis began in the 1920s, as the Bureau of Narcotics, led by Harry Anslinger, sought to expand its jurisdiction and to create a role for itself in the emerging field of drug control. Anslinger, who served as commissioner of the bureau from 1930 to 1962, was a master of bureaucratic politics and public relations, and he saw cannabis as an opportunity to build his agency's power and prestige.
Anslinger's campaign against cannabis was explicitly racialized. He linked the plant to Mexican immigrants, African Americans, and other marginalized groups, portraying them as threats to white America. In testimony before Congress and in articles for popular magazines, Anslinger claimed that cannabis caused violence, insanity, and moral degeneracy, and he cited sensational cases of crimes committed by "marihuana fiends" to support his claims. The evidence for these claims was thin, but they resonated with a public that was anxious about immigration and social change.
The Marihuana Tax Act of 1937, which effectively prohibited cannabis in the United States, was the culmination of Anslinger's campaign. The act did not make cannabis illegal per se but imposed a tax on its sale and required registration for anyone dealing in it. The tax was set at a prohibitive level, and the registration requirements were so burdensome that compliance was effectively impossible. The act passed with little debate, and it was signed into law by President Franklin D. Roosevelt on August 2, 1937.
The passage of the Marihuana Tax Act was not the beginning of cannabis prohibition in the United States. Many states had already banned the plant, and local laws against it were common. But the federal act made prohibition national, and it set the stage for the expansion of federal drug control in the decades that followed. The act was also a model for international drug control, as the United States pressed other countries to adopt similar prohibitions.
The American campaign against cannabis was part of a broader movement for drug prohibition that emerged in the early twentieth century. The Pure Food and Drug Act of 1906, the Harrison Narcotics Act of 1914, and the Eighteenth Amendment (Prohibition) of 1919 all reflected a growing belief that the federal government should regulate the use of drugs and alcohol. The campaign against cannabis was an extension of this movement, though it came later and was driven by different concerns.
The racial dimensions of cannabis prohibition were not unique to the United States. In other countries, cannabis was also associated with marginalized groups and used as a tool of social control. In South Africa, the prohibition of dagga was used to control African workers. In Jamaica, the prohibition of ganja was used to suppress the Rastafari movement. In Mexico, the prohibition of marijuana was used to control the rural poor. The pattern was consistent: cannabis was banned not because it was inherently dangerous but because it was associated with people whom the authorities wanted to control.
The legacy of the Marihuana Tax Act and the prohibitionist policies that followed it has been profound. The act made cannabis illegal, and the laws that followed—the Boggs Act of 1952, the Narcotics Control Act of 1956, and the Controlled Substances Act of 1970—established the framework for cannabis prohibition that lasted for nearly a century. The costs of that prohibition have been enormous: millions of arrests, billions of dollars spent on enforcement, and the creation of a vast illicit market that has fueled violence and corruption around the world.
Chapter Twenty‑Two: International Drug Control and the Global Prohibition Regime
The prohibition of cannabis was not merely a national phenomenon but was part of a global movement to control drugs that emerged in the early twentieth century. The international drug control system, which began with the International Opium Convention of 1912 and evolved through a series of treaties and conventions, created a global prohibition regime that made cannabis illegal in most countries and established the framework for international cooperation in drug enforcement.
The United States was a driving force behind the international drug control system. American policymakers, concerned about the spread of opium and other drugs, pressed for international agreements that would restrict their production and trade. The International Opium Convention of 1912, which was signed by thirteen nations, was the first step in this process, though it focused on opium and cocaine rather than cannabis.
Cannabis was added to the international drug control system in 1925, at the Second International Opium Conference in Geneva. The Egyptian delegation, concerned about the spread of hashish in their country, pressed for the inclusion of cannabis in the convention, and the Indian delegation, which had a long history of cannabis use, opposed it. The compromise that emerged placed cannabis under the same controls as opium and cocaine, though it allowed for its use for medical and scientific purposes.
The international drug control system was strengthened by subsequent treaties, including the Single Convention on Narcotic Drugs of 1961, which consolidated earlier agreements and established the International Narcotics Control Board (INCB) to oversee their implementation. The Single Convention classified cannabis as a Schedule I drug, meaning that it was considered to have a high potential for abuse and no accepted medical use—a classification that was contradicted by centuries of medical practice but that reflected the political consensus of the time.
The United Nations Convention on Psychotropic Substances of 1971 extended the control system to other drugs, including synthetic cannabinoids, and the Convention Against Illicit Traffic in Narcotic Drugs and Psychotropic Substances of 1988 strengthened the enforcement mechanisms. By the 1990s, the international drug control system had become a global regime, with nearly every country in the world a party to one or more of the conventions and with a complex apparatus of treaties, organizations, and enforcement mechanisms.
The international drug control system has had a profound impact on cannabis policy around the world. It has made cannabis illegal in most countries, and it has provided the framework for international cooperation in drug enforcement, including extradition, asset forfeiture, and the sharing of intelligence. The system has also been used to pressure countries that have liberalized their cannabis laws, with the United States and other countries threatening to cut off aid or impose sanctions on nations that deviate from the prohibitionist consensus.
The international drug control system has also been criticized for its inflexibility and its failure to adapt to changing circumstances. The classification of cannabis as a Schedule I drug, which was based on political considerations rather than scientific evidence, has made it difficult to conduct research on the plant and has hindered the development of medical cannabis programs. The system's focus on enforcement rather than public health has contributed to the harms of prohibition, including mass incarceration and the empowerment of criminal organizations.
In recent years, there have been calls for reform of the international drug control system. The United Nations has acknowledged the need for a more flexible approach, and some countries have begun to liberalize their cannabis laws despite their treaty obligations. The tension between national policies and international law is likely to intensify in the coming years, as more countries move toward legalization and the prohibitionist consensus continues to erode.
Chapter Twenty‑Three: The War on Drugs and Its Consequences
The war on drugs, declared by President Richard Nixon in 1971 and intensified by every subsequent administration, transformed cannabis prohibition from a relatively minor area of law enforcement into a massive apparatus of policing, incarceration, and international intervention. The war on drugs has had consequences that were never intended and that have shaped American society in profound ways.
Nixon's declaration of war on drugs was motivated in part by political calculations. His aides later acknowledged that the war was aimed at two groups: anti-war protesters and African Americans. By associating these groups with drug use, Nixon sought to discredit them and to build support for his administration. The war on drugs was, from its inception, a political project as much as a public health initiative.
The escalation of the war on drugs under Ronald Reagan in the 1980s had even more dramatic consequences. The Anti-Drug Abuse Act of 1986 established mandatory minimum sentences for drug offenses, including cannabis, and created the sentencing disparities that led to the mass incarceration of African Americans and Latinos. The act also increased funding for law enforcement and established the Office of National Drug Control Policy, which coordinated federal drug policy.
The consequences of the war on drugs have been devastating. The United States, with 5 percent of the world's population, has 25 percent of the world's prisoners, and drug offenses account for a large share of that incarceration. African Americans are arrested for cannabis offenses at rates far higher than whites, despite similar rates of use, and the collateral consequences of these arrests—loss of voting rights, difficulty finding employment, barriers to housing and education—have compounded the harms of the drug war.
The war on drugs has also had international consequences. The United States has pressured other countries to adopt prohibitionist policies, and it has provided funding and training for drug enforcement efforts around the world. The militarization of drug enforcement in Latin America has contributed to violence, corruption, and political instability in countries like Mexico, Colombia, and Honduras. The aerial spraying of herbicides to destroy cannabis crops has caused environmental damage and health problems for rural communities.
The war on drugs has also failed in its stated goals. Despite decades of enforcement, cannabis use has not declined, and the potency of cannabis has increased. The illicit market, which was supposed to be eliminated by prohibition, has become more sophisticated and more violent. And the costs of enforcement have escalated, with the United States spending more than a trillion dollars on drug control since the war was declared.
The failure of the war on drugs has led to a growing recognition that prohibition is not working. The movement for drug policy reform, which began in the 1990s with medical cannabis, has grown to include advocates for decriminalization, legalization, and harm reduction. The shift in public opinion has been dramatic: in 1970, only 12 percent of Americans favored legalization; by 2024, more than 70 percent did.
The war on drugs has left a legacy that will take generations to overcome. The mass incarceration of people of color has devastated communities, and the collateral consequences of drug convictions have created barriers to opportunity that persist long after sentences have been served. The militarization of policing has eroded trust between law enforcement and communities, and the erosion of civil liberties has made all Americans less free. The end of the war on drugs, if it comes, will be a beginning, not an end, of the work of repair.
Part VIII: Cannabis in the Twentieth Century
Chapter Twenty‑Four: Jazz, Bohemia, and the Underground
The prohibition of cannabis did not end its use; it merely drove it underground. In the 1920s, 1930s, and 1940s, cannabis found new life in the jazz clubs of Harlem, the bohemian enclaves of Greenwich Village and North Beach, and the countercultural movements that would later explode in the 1960s. The association of cannabis with music, art, and rebellion was forged in these years, and it has shaped the cultural meaning of the plant ever since.
The jazz musicians of the 1920s and 1930s were among the most prominent users of cannabis in the prohibition era. Musicians like Louis Armstrong, Cab Calloway, and Duke Ellington used cannabis, and they celebrated it in their music and their language. The word "marihuana" entered the jazz lexicon, and songs like "Sweet Marihuana" and "The Weed Smoker's Dream" reflected the plant's place in jazz culture.
The association of cannabis with jazz was not merely recreational. Musicians found that cannabis could enhance their creativity, helping them to improvise and to enter the flow states that were essential to their art. The drug also served as a social lubricant, creating bonds among musicians and fostering the sense of community that was central to the jazz scene. And the illegal status of cannabis added an element of danger and rebellion that appealed to musicians who saw themselves as outsiders.
The Harlem Renaissance, which flourished in the 1920s and 1930s, was another context in which cannabis was used and celebrated. Writers, artists, and intellectuals in Harlem used cannabis, and they incorporated it into their work. The poet Langston Hughes wrote about cannabis in his memoir The Big Sea, describing the "tea" parties that were a feature of Harlem nightlife. The novelist Claude McKay mentioned cannabis in his work, and the painter Aaron Douglas may have used it as well.
The bohemian subcultures of the 1940s and 1950s also embraced cannabis. The Beat Generation writers—Allen Ginsberg, Jack Kerouac, William S. Burroughs—used cannabis and wrote about it in their work. Ginsberg's poem "Howl," which became a manifesto of the Beat movement, mentions cannabis among the drugs that his generation used to escape the conformity of postwar America. The Beats saw cannabis not merely as a pleasure but as a tool for consciousness expansion, a way of breaking through the constraints of conventional thinking.
The Beat movement also contributed to the development of a cannabis culture that was explicitly oppositional. The Beats rejected the values of mainstream America—consumerism, conformity, the Cold War—and they saw cannabis as a symbol of that rejection. The use of cannabis was a form of rebellion, a way of asserting the primacy of individual experience over social expectations. This oppositional stance would be carried forward by the counterculture of the 1960s.
The underground cannabis culture of the prohibition era was not limited to artists and intellectuals. Ordinary people used cannabis as well, though they were less visible in the historical record. The plant was used by workers, by housewives, by students, and by soldiers, though the risks of arrest made discretion necessary. The culture of cannabis use that developed in the prohibition era was characterized by secrecy, by shared rituals, and by a sense of community among those who used the drug.
The enforcement of cannabis prohibition in the prohibition era was uneven. In some cities, police turned a blind eye to cannabis use in jazz clubs and bohemian enclaves, perhaps because they saw it as a harmless vice or because they were focused on more serious crimes. In other places, enforcement was aggressive, and the penalties for cannabis possession could be severe. The threat of arrest hung over cannabis users, adding to the sense of danger and rebellion that surrounded the drug.
The legacy of the jazz and Beat eras for cannabis culture is profound. The association of cannabis with creativity, with rebellion, and with community was forged in these years, and it has persisted to the present day. The language of cannabis culture—the slang, the rituals, the etiquette—has its roots in these subcultures. And the sense that cannabis use is a form of resistance to authority, a way of asserting individual freedom, continues to animate the movement for legalization.
Chapter Twenty‑Five: The 1960s Counterculture and the Politics of Consciousness
The 1960s were a watershed decade in the history of cannabis. The counterculture that emerged in that decade embraced cannabis as a sacrament, a tool for consciousness expansion, and a symbol of resistance to the Vietnam War, racial injustice, and the conformity of American life. The explosion of cannabis use among young people in the 1960s transformed the drug's cultural meaning and set the stage for the political battles that would follow.
The counterculture's embrace of cannabis was part of a broader exploration of altered states of consciousness. The use of psychedelic drugs like LSD and psilocybin, promoted by figures like Timothy Leary and Ken Kesey, inspired a generation to seek expanded awareness through chemical means. Cannabis, which was more widely available and less intense than LSD, became the entry point for many into this exploration, and it remained a staple of the counterculture even as interest in psychedelics waned.
The association of cannabis with the anti-war movement was particularly significant. Young people who opposed the Vietnam War saw cannabis as a symbol of their rejection of the values that had led to the war—authoritarianism, militarism, materialism. The use of cannabis was a form of protest, a way of saying no to the draft, to the corporate economy, to the whole apparatus of American power. The slogan "Turn on, tune in, drop out" captured this ethos: cannabis was a means of disconnecting from the dominant culture and connecting to an alternative community.
The counterculture also created new forms of cannabis use and distribution. The communal sharing of cannabis, often in the form of hand-rolled cigarettes called joints, became a ritual of bonding and solidarity. The distribution of cannabis, often through informal networks of friends and acquaintances, created a sense of community among users. And the cultivation of cannabis, which had been largely imported from Mexico, began to move indoors, as growers developed techniques for producing the plant in closets and basements.
The music of the 1960s was inseparable from cannabis. Rock bands like the Beatles, the Rolling Stones, and Bob Dylan used cannabis, and they wrote songs about it. Dylan's "Rainy Day Women #12 & 35" ("Everybody must get stoned") became an anthem of the counterculture, and the Beatles' "Yellow Submarine" was interpreted by some as a drug song. Music festivals like Woodstock, which brought together hundreds of thousands of young people, were occasions for mass cannabis use, and the drug became part of the soundtrack of the era.
The explosion of cannabis use in the 1960s provoked a backlash from the political establishment. President Richard Nixon declared war on drugs in 1971, and his administration increased funding for drug enforcement and expanded the powers of law enforcement agencies. The Controlled Substances Act of 1970, which classified cannabis as a Schedule I drug—the most restrictive category—established the legal framework for the war on drugs that would follow.
But the backlash also galvanized the movement for drug policy reform. The National Organization for the Reform of Marijuana Laws (NORML), founded in 1970, began to advocate for the decriminalization of cannabis, and a number of states passed decriminalization laws in the 1970s. The movement was small and its victories were limited, but it laid the groundwork for the more ambitious reforms that would come later.
The cultural legacy of the 1960s for cannabis is still with us. The association of cannabis with creativity, with rebellion, and with community—forged in the jazz and Beat eras and amplified by the counterculture—remains central to the plant's meaning. The political struggles of the 1960s—over war, over race, over the role of government—continue to shape the debate over cannabis policy. And the generation that came of age in the 1960s, now in its 70s and 80s, has been a powerful force for legalization, bringing to the cause the idealism and the commitment that they learned in their youth.
Chapter Twenty‑Six: Reggae, Rastafari, and Global Symbolism
If the 1960s counterculture gave cannabis a new meaning in the United States, the Rastafari movement of Jamaica gave it a new meaning for the world. The Rastafari, who emerged in the 1930s as a religious and political movement among the poor of Jamaica, made cannabis—known as ganja—a sacrament, a tool for spiritual insight, and a symbol of resistance to oppression. Through the music of Bob Marley and other reggae artists, Rastafari's cannabis culture spread around the world, shaping the global symbolism of the plant.
The Rastafari movement's reverence for cannabis is rooted in both African and Indian traditions. The African slaves who were brought to Jamaica brought with them traditions of cannabis use, and the Indian indentured laborers who came to the island after emancipation brought their own traditions, including the worship of Shiva and the consumption of bhang. Rastafari synthesized these traditions, creating a distinctive cannabis culture that was explicitly religious.
For Rastafari, cannabis is a sacrament, a means of achieving spiritual insight and connecting with the divine. The use of cannabis is grounded in the biblical passage in which God says, "I have given you every herb bearing seed" (Genesis 1:29), which Rastafari interpret as a divine endorsement of cannabis use. The drug is used in rituals called "reasoning sessions," in which Rastafari gather to discuss spiritual matters, to chant, and to smoke ganja from a communal pipe called a chillum.
The Rastafari movement's association of cannabis with resistance to oppression gave the plant a political meaning that resonated with marginalized people around the world. Rastafari emerged in the context of Jamaican poverty, racism, and colonialism, and the movement saw cannabis as a tool for liberation—a way of breaking free from the mental shackles of oppression and connecting with African identity and heritage. The use of cannabis was an act of resistance, a refusal to accept the values and the authority of the colonial power.
Bob Marley, who became the global face of Rastafari, was instrumental in spreading the movement's cannabis culture. Marley's music, which combined reggae rhythms with lyrics about love, justice, and liberation, introduced Rastafari to audiences around the world. Songs like "Kaya," "Easy Skanking," and "Jah Live" celebrated cannabis as a sacrament, and Marley's image—long dreadlocks, red-green-and-yellow cap, a spliff in hand—became synonymous with the plant. Marley's death from cancer in 1981 only enhanced his status as a cannabis icon.
The influence of Rastafari on global cannabis culture has been profound. The language of Rastafari—words like "Irie," "Jah," and "Livity"—entered the vocabulary of cannabis users around the world. The association of cannabis with dreadlocks, reggae music, and resistance to oppression became part of the plant's global symbolism. And the Rastafari interpretation of cannabis as a sacrament, a tool for spiritual insight, influenced the development of cannabis culture in Europe, North America, and beyond.
The Rastafari movement has also faced challenges. The Jamaican government, which prohibited cannabis in the early twentieth century, enforced prohibition with particular severity against Rastafari, who were seen as a threat to social order. Rastafari were arrested, beaten, and their communities were raided by police. The persecution of Rastafari for their cannabis use became a cause célèbre for the movement, and it helped to galvanize support for the legalization of cannabis.
In recent years, the Jamaican government has moved to recognize Rastafari's religious use of cannabis. A 2015 law decriminalized the possession of small amounts of cannabis and legalized its use for religious purposes, allowing Rastafari to use cannabis in their ceremonies without fear of arrest. The move was a recognition of the centrality of cannabis to Rastafari identity and a step toward redressing the injustices of the prohibition era.
Part IX: The Modern Era
Chapter Twenty‑Seven: Legalization and the End of Prohibition
The movement to end cannabis prohibition began in the 1990s with the passage of medical cannabis laws in California and other states, and it culminated in the 2010s with the legalization of adult-use cannabis in Colorado, Washington, and other jurisdictions. The shift from prohibition to legalization has been one of the most rapid and dramatic policy changes in American history, and its consequences are still unfolding.
The first adult-use cannabis laws were passed in Colorado and Washington in 2012, following ballot initiatives that won with substantial majorities. The laws allowed for the sale of cannabis through licensed dispensaries, regulated the production and distribution of the drug, and imposed taxes on its sale. The implementation of these laws was closely watched by policymakers around the world, as they represented a radical departure from the prohibitionist policies that had been in place for nearly a century.
The early results from Colorado and Washington were encouraging. Cannabis use increased modestly, but not dramatically, and there was no increase in youth use. Tax revenues from cannabis sales exceeded expectations, providing funding for schools, infrastructure, and drug treatment programs. And the illicit market for cannabis shrank, as consumers switched to legal sources. The success of these programs encouraged other states to follow suit, and by 2024, more than twenty states had legalized adult-use cannabis.
The legalization movement has not been limited to the United States. Uruguay became the first country in the world to legalize cannabis in 2013, establishing a system of state-regulated production and sale. Canada legalized adult-use cannabis in 2018, creating a federal regulatory framework that has been followed by other countries. Mexico, which had been a major producer of cannabis for the American market, legalized cannabis in 2021, and other Latin American countries are considering similar moves.
The legalization of cannabis has created a new industry, one that has grown rapidly and has attracted investment from around the world. The cannabis industry includes cultivators, processors, distributors, retailers, and ancillary businesses that provide services like testing, marketing, and consulting. The industry has created jobs, generated tax revenue, and provided consumers with access to safe, tested products. But it has also faced challenges, including banking restrictions, regulatory uncertainty, and competition from the illicit market.
The legalization movement has also raised questions about the role of corporate interests in the cannabis industry. Critics argue that the industry has been captured by large corporations that prioritize profits over social equity, and that the benefits of legalization have not been shared equitably. The legacy of prohibition—the mass incarceration of people of color for cannabis offenses—has not been addressed by legalization, and many advocates argue that social equity should be a central goal of cannabis policy.
The international implications of legalization are still being worked out. The United States, as a party to international drug control treaties, is technically in violation of its treaty obligations, and other countries have complained about the inconsistency of American policy. The tension between national laws and international treaties is likely to lead to calls for reform of the international drug control system, and the United Nations has acknowledged the need for a more flexible approach.
The end of cannabis prohibition in the United States is not yet complete. Cannabis remains illegal under federal law, and the conflict between state and federal law has created legal uncertainty for the industry. The banking system, which is federally regulated, has been largely closed to cannabis businesses, forcing them to operate in cash and creating security risks. And the lack of a federal regulatory framework has led to inconsistencies in product safety, labeling, and testing.
Despite these challenges, the momentum toward legalization is clear. Public support for legalization has grown steadily, and the political calculus of prohibition has shifted. The war on drugs, which was once a political winner, is now seen as a failure, and the harms of prohibition—mass incarceration, racial disparities, violence—are increasingly difficult to defend. The end of cannabis prohibition is not a matter of if, but when, and the transition from prohibition to legalization will be one of the most significant policy shifts of the twenty-first century.
Chapter Twenty‑Eight: The Cannabis Industry: From Underground to Mainstream
The legalization of cannabis has created a new industry, one that has grown from a clandestine underground to a legitimate business sector in less than a decade. The cannabis industry is now worth billions of dollars, and it includes a complex ecosystem of cultivators, processors, distributors, retailers, and ancillary businesses. The industry has created jobs, generated tax revenue, and provided consumers with access to safe, tested products. But it has also faced challenges, including regulatory uncertainty, competition from the illicit market, and the legacy of prohibition.
The structure of the cannabis industry varies by jurisdiction, but there are common patterns. Cultivators grow the plant in indoor facilities, greenhouses, or outdoor fields, using advanced techniques to control light, temperature, and nutrients. Processors extract the active compounds from the plant, creating concentrates, edibles, and other products. Distributors transport the products to retailers, who sell them to consumers. The industry also includes testing laboratories, which ensure product safety and potency, and ancillary businesses that provide services like security, marketing, and consulting.
The cannabis industry has been characterized by rapid growth and volatility. The industry grew rapidly in the early years of legalization, attracting investment from venture capitalists and large corporations. But the industry has also experienced boom-and-bust cycles, as oversupply, price compression, and regulatory uncertainty have created challenges for businesses. The COVID-19 pandemic, which led to the closure of many businesses and the disruption of supply chains, also affected the industry, though cannabis was deemed an essential business in many jurisdictions and saw increased sales.
The consolidation of the cannabis industry has been a major trend. Large corporations, including tobacco and alcohol companies, have entered the industry, acquiring smaller businesses and building vertically integrated operations. The consolidation has raised concerns about the concentration of power in the industry and the marginalization of small businesses and social equity applicants. The industry has also seen the emergence of branded products, with companies developing distinctive brands that appeal to different segments of the market.
The labor conditions in the cannabis industry have been a subject of concern. The industry has created jobs, but many of those jobs are low-wage and precarious, and workers have faced challenges in organizing for better conditions. The legacy of prohibition has also affected labor relations, as workers in the industry have been subject to drug testing and other forms of surveillance that are not applied to workers in other industries. The movement to unionize the cannabis industry has gained momentum in recent years, with workers in California, Colorado, and other states organizing for better wages and working conditions.
The illicit market for cannabis has not disappeared with legalization. In many jurisdictions, the illicit market continues to thrive, offering lower prices, greater variety, and fewer regulations than the legal market. The persistence of the illicit market has been a challenge for the legal industry, and it has led to calls for lower taxes, fewer regulations, and greater enforcement against illegal operators. The relationship between the legal and illicit markets is complex, and it will take time for the legal market to mature and to capture a larger share of the overall market.
The global cannabis industry is still in its infancy. Countries like Canada, Uruguay, and Mexico have legalized cannabis, and other countries are considering similar moves. The export market for cannabis is also developing, with countries like Israel, the Netherlands, and Colombia positioning themselves as suppliers for the global market. The international cannabis trade is constrained by the international drug control treaties, but the momentum toward legalization is likely to lead to changes in those treaties in the coming years.
The cannabis industry faces a number of challenges in the coming years. The conflict between state and federal law in the United States creates uncertainty for businesses and limits their access to banking, capital, and markets. The lack of a federal regulatory framework leads to inconsistencies in product safety, labeling, and testing. And the legacy of prohibition—the mass incarceration of people of color for cannabis offenses—has not been addressed by legalization, creating tensions between the industry and the communities that were most harmed by the drug war.
Despite these challenges, the cannabis industry is poised for continued growth. Public support for legalization is strong, and the political momentum is toward further liberalization. The industry has shown remarkable resilience in the face of adversity, and it has the potential to become a major sector of the economy in the coming years. The transition from prohibition to legalization is a work in progress, and the shape of the industry in the future will be determined by the choices that policymakers, businesses, and consumers make in the years ahead.
Chapter Twenty‑Nine: Social Equity and the Legacy of Prohibition
The legalization of cannabis has created an opportunity to address the harms of prohibition, but it has also raised questions about who benefits from the new industry and who is left behind. The movement for social equity in cannabis seeks to ensure that the communities that were most harmed by the war on drugs—communities of color, low-income communities, and others—have a share in the benefits of legalization.
The legacy of prohibition is stark. Between 2001 and 2010, there were more than 8 million cannabis arrests in the United States, and African Americans were 3.7 times more likely than whites to be arrested for cannabis possession, despite similar rates of use. The collateral consequences of these arrests—loss of voting rights, difficulty finding employment, barriers to housing and education—have compounded the harms of the drug war. The mass incarceration of people of color for cannabis offenses has devastated communities and created a legacy that will take generations to overcome.
Social equity programs in the cannabis industry seek to address these harms. These programs typically include provisions for the expungement of cannabis convictions, the prioritization of licenses for people from communities that were disproportionately affected by prohibition, and the provision of technical assistance, capital, and other resources to social equity applicants. The goal is to create a cannabis industry that reflects the diversity of the communities it serves and that provides opportunities for those who were most harmed by prohibition.
The implementation of social equity programs has been challenging. In many jurisdictions, the programs have been underfunded, understaffed, and poorly designed. The high costs of entry into the cannabis industry—licensing fees, real estate, equipment—have made it difficult for social equity applicants to compete with large corporations. And the complexity of the regulatory environment has created barriers that are difficult for people with limited resources to overcome.
The tension between social equity and corporate interests has been a central theme in the politics of legalization. Large corporations, which have the capital and expertise to dominate the industry, have often opposed social equity provisions that would limit their access to licenses or that would create preferences for small businesses. The advocates for social equity have argued that the industry has a moral obligation to address the harms of prohibition, and that the benefits of legalization should be shared broadly.
The movement for social equity has had some successes. In California, the state has allocated funds for social equity programs and has created a system of licensing preferences for social equity applicants. In Massachusetts, the state has prioritized licenses for social equity applicants and has provided technical assistance and capital to help them succeed. In other states, social equity programs are in their early stages, and it is too early to assess their effectiveness.
The challenges of social equity are not limited to the United States. In Canada, which legalized cannabis in 2018, there has been concern about the lack of diversity in the cannabis industry and about the exclusion of indigenous peoples and other marginalized groups. In other countries, the movement for social equity is in its early stages, and the lessons from the American experience are being studied.
The ultimate goal of social equity is not merely to create a diverse cannabis industry but to address the underlying harms of prohibition. This requires not only licensing preferences and capital assistance but also investment in communities, education, health care, and other services that were neglected during the war on drugs. It requires the expungement of cannabis convictions and the restoration of voting rights and other civil liberties. And it requires a commitment to justice that goes beyond the cannabis industry to the broader project of repairing the harms of the drug war.
Chapter Thirty: Medicine, Science, and the Future of Cannabis
The future of cannabis is being shaped by science as much as by policy. The discovery of the endocannabinoid system, the development of new cannabis-based drugs, and the growing body of research on the therapeutic effects of cannabis are transforming our understanding of the plant and its potential. The next chapter in the history of cannabis will be written in laboratories, clinical trials, and regulatory agencies as much as in legislatures and courtrooms.
The scientific study of cannabis has advanced rapidly in recent years. Researchers have identified more than one hundred cannabinoids and dozens of terpenes in the plant, and they are beginning to understand how these compounds interact with each other and with the human body. The "entourage effect"—the idea that the compounds in cannabis work together synergistically to produce their effects—has become a central concept in cannabis science, though it is still being investigated.
The therapeutic potential of cannabis is being explored for a wide range of conditions. The evidence is strongest for chronic pain, nausea and vomiting from chemotherapy, and muscle spasticity from multiple sclerosis. For these conditions, cannabis or cannabis-based drugs have been shown to be effective, and they are increasingly being used in clinical practice. The evidence for other conditions—anxiety, depression, post-traumatic stress disorder, sleep disorders, and others—is less robust, but it is growing.
The development of cannabis-based drugs is a major focus of the pharmaceutical industry. Epidiolex, a CBD-based drug for certain forms of epilepsy, was approved by the FDA in 2018, and other drugs are in development. These drugs offer the advantages of standardization, precise dosing, and regulatory approval, and they have the potential to bring the benefits of cannabis to patients who may be reluctant to use the raw plant.
The risks of cannabis use are also being studied. The effects of THC on the developing brain, particularly in adolescents, have been documented, and the drug's potential to induce psychosis in vulnerable individuals has been investigated. The respiratory effects of smoking cannabis have been studied, and the risks of cannabis use disorder, a form of addiction, have been characterized. The scientific understanding of these risks is informing public health policies and is shaping the debate over legalization.
The future of cannabis science is likely to be shaped by advances in genetics, neuroscience, and pharmacology. The sequencing of the cannabis genome has opened new possibilities for breeding plants with specific chemical profiles, and the development of new analytical techniques has made it possible to study the plant's effects in unprecedented detail. The integration of cannabis science with the broader field of neuroscience is likely to yield insights into the nature of consciousness, the mechanisms of mental illness, and the potential for new treatments.
The regulatory environment for cannabis research is also changing. The federal prohibition of cannabis in the United States has made it difficult for researchers to study the plant, but the easing of restrictions in recent years has opened new opportunities. The National Institutes of Health have increased funding for cannabis research, and the Drug Enforcement Administration has approved new sources of cannabis for research purposes. The result is a growing body of scientific knowledge that is informing policy and practice.
The future of cannabis is not predetermined. It will be shaped by the choices that societies make about how to regulate the plant, by the investments that are made in research and public health, and by the ways that people incorporate cannabis into their lives. The history of cannabis is a story of adaptation and change, and the next chapter of that story is being written now.
Conclusion: The Plant in History
The history of cannabis is a history of human beings trying to make sense of a plant that has always been more than any single use or meaning. It is a plant of fibers and flowers, of medicine and intoxication, of industry and spirit. It has been woven into the fabric of civilizations, from the hemp fields of ancient China to the cannabis dispensaries of modern America. It has been a source of sustenance and of danger, of healing and of harm, of community and of division.
The story of cannabis is also a story of human beings making choices about how to relate to the natural world. For most of human history, cannabis was integrated into the rhythms of daily life, used for practical purposes, for healing, and for ritual. The decision to prohibit cannabis, which began in the early twentieth century and spread around the world, was a departure from that long history. It was a choice to treat the plant as an enemy, to criminalize its use, and to punish those who used it.
The consequences of that choice have been profound. The war on cannabis has cost billions of dollars, has led to the incarceration of millions of people, and has fueled violence and corruption around the world. It has devastated communities, destroyed families, and eroded civil liberties. And it has failed in its stated goals: cannabis use has not declined, and the harms of the plant—to the extent that they exist—have not been prevented by prohibition.
The movement to end prohibition is a recognition that this experiment has failed. The legalization of cannabis in many jurisdictions is a return to the older tradition of integration, in which the plant is treated not as an enemy but as a substance that can be used responsibly or irresponsibly, and that can be regulated for the public good. The shift from prohibition to regulation is a work in progress, and its outcomes are uncertain. But it represents a change in the relationship between human beings and this ancient plant.
As this book goes to press, the history of cannabis is still being written. New research is deepening our understanding of the plant's effects, new policies are reshaping its legal status, and new cultures are emerging around its use. The story that began in the grasslands of Central Asia, that moved through the great civilizations of the ancient world, that fueled the maritime empires of Europe, that was suppressed by the prohibitionists of the twentieth century, and that is now being transformed by the legalization movement of the twenty-first century, is not over. It is, in many ways, just beginning.
The history of cannabis is not a history of a single substance but a history of human beings and their relationship with the natural world. It is a story of how a plant can be many things to many people, and of how those meanings change over time. It is a story of how societies make choices about what to encourage and what to forbid, and of how those choices shape the lives of individuals and communities. It is a story that teaches us about ourselves—about our desires, our fears, and our capacity for both wisdom and folly.
In the end, the history of cannabis is a history of freedom: the freedom to use a plant that has been part of human experience for millennia, and the freedom to make choices about how to live our lives. It is a history that reminds us that prohibition has costs as well as benefits, and that the balance of those costs and benefits must be weighed carefully. And it is a history that suggests that the future of cannabis, like its past, will be shaped not by the plant itself but by the people who use it, who regulate it, and who write its story.
Epilogue: The Return of the Plant
On a hillside in the Emerald Triangle of Northern California, a young farmer tends to her plants as the summer sun beats down. Her grandfather grew cannabis in these hills in the 1970s, when the plant was illegal and the cultivation was done in secret, hidden from the helicopters that patrolled the skies. Her father grew in the 1990s, when medical cannabis was legal in California but the federal government still raided farms and sent growers to prison. She grows in the 2020s, in a state where cannabis is fully legal, where her products are tested in laboratories, and where she pays taxes on her income.
The plants she tends are not the same as the plants her grandfather grew. They are hybrids, bred for specific chemical profiles, tested for potency and purity. They are grown from seeds that have been selected over generations for their yield, their flavor, and their effects. They are the product of ten thousand years of human selection, of a relationship between people and plants that has been refined and transformed across centuries and continents.
As she works, the farmer thinks about the long history that has brought her to this hillside. She thinks about the ancestors who first cultivated cannabis in Central Asia, about the Chinese emperors who prescribed it for their ailments, about the Indian sadhus who smoked it in honor of Shiva. She thinks about the sailors who depended on hemp for their ships, about the slaves who were forced to cultivate it, about the jazz musicians who celebrated it in their songs. She thinks about the activists who fought for its legalization, about the patients who used it to ease their suffering, about the people who were imprisoned for possessing it.
She thinks about the future as well. She thinks about the children who will grow up in a world where cannabis is not a crime, about the scientists who will discover new uses for the plant, about the entrepreneurs who will build businesses around it. She thinks about the communities that were devastated by the war on drugs and the work that remains to repair that damage. She thinks about the choices that will shape the future of the plant and the people who use it.
The sun sets over the hills, and the farmer packs her tools and heads home. She leaves the plants to do what they have done for ten thousand years: to grow toward the sun, to produce their flowers, to fulfill their ancient purpose. The history of cannabis is not a story that ends; it is a story that continues, season after season, generation after generation, as people and plants find new ways to live together on this earth.
Bibliography
The following is a selection of the most important works consulted in the preparation of this manuscript.
Booth, Martin. Cannabis: A History. New York: St. Martin's Press, 2003.
Clarke, Robert Connell, and Mark D. Merlin. Cannabis: Evolution and Ethnobotany. Berkeley: University of California Press, 2013.
Duvall, Chris. Cannabis. London: Reaktion Books, 2014.
Lee, Martin A. Smoke Signals: A Social History of Marijuana—Medical, Recreational, and Scientific. New York: Scribner, 2012.
Mikuriya, Tod H., ed. Marijuana: Medical Papers, 1839‑1972. Oakland: Medi‑Comp Press, 1973.
Abel, Ernest L. Marihuana: The First Twelve Thousand Years. New York: Plenum Press, 1980.
Bennett, Chris, and Neil McQueen. Sex, Drugs, Violence and the Bible. Forbidden Fruit Publishing, 2001.
Li, Hui‑Lin. "An Archaeological and Historical Account of Cannabis in China." Economic Botany 28, no. 4 (1974): 437‑448.
Merlin, Mark D. Man and Marijuana: Some Aspects of Their Ancient Relationship. Rutherford: Fairleigh Dickinson University Press, 1972.
Russo, Ethan B. "History of Cannabis and Its Preparations in Saga, Science, and Sobriquet." Chemistry & Biodiversity 4, no. 8 (2007): 1614‑1648.
Anslinger, Harry J., and Will Oursler. The Murderers: The Story of the Narcotic Gangs. New York: Farrar, Straus and Cudahy, 1961.
Courtwright, David T. Dark Paradise: A History of Opiate Addiction in America. Cambridge: Harvard University Press, 1982.
Dufton, Emily. Grass Roots: The Rise and Fall and Rise of Marijuana in America. New York: Basic Books, 2017.
Musto, David F. The American Disease: Origins of Narcotic Control. New Haven: Yale University Press, 1973.
Sloman, Larry. Reefer Madness: A History of Marijuana. New York: St. Martin's Press, 1979.
Grinspoon, Lester. Marihuana Reconsidered. Cambridge: Harvard University Press, 1971.
Iversen, Leslie L. The Science of Marijuana. Oxford: Oxford University Press, 2008.
Mechoulam, Raphael, ed. Cannabinoids as Therapeutic Agents. Boca Raton: CRC Press, 1986.
Pertwee, Roger G., ed. Cannabinoids. New York: Springer, 2005.
Pertwee, Roger G. "Cannabinoid Pharmacology: The First 66 Years." British Journal of Pharmacology 147, no. S1 (2006): S163‑S171.
Berridge, Virginia, and Griffith Edwards. Opium and the People: Opiate Use in Nineteenth‑Century England. London: St. Martin's Press, 1981.
Campos, Isaac. Home Grown: Marijuana and the Origins of Mexico's War on Drugs. Chapel Hill: University of North Carolina Press, 2012.
Chevannes, Barry. Rastafari: Roots and Ideology. Syracuse: Syracuse University Press, 1994.
Klein, Axel, Marcus Day, and Anthony Harriott, eds. Caribbean Drugs: From Criminalization to Harm Reduction. London: Zed Books, 2004.
Werb, Dan. The Inevitable: Inside the Messy, Unstoppable Transition to Legal Pot. New York: Simon & Schuster, 2022.
The Atharva Veda. Translated by Maurice Bloomfield. Oxford: Oxford University Press, 1897.
Dioscorides. De Materia Medica. Translated by Tess Anne Osbaldeston. Johannesburg: Ibidis Press, 2000.
Herodotus. The Histories. Translated by Aubrey de Sélincourt. London: Penguin Books, 1954.
O'Shaughnessy, William Brooke. "On the Preparations of the Indian Hemp, or Gunjah." Transactions of the Medical and Physical Society of Bengal (1839): 421‑461.
Shennong Bencao Jing. Translated by Sabine Wilms. Taos: Happy Goat Productions, 2015.
United States. The Marihuana Tax Act of 1937. Public Law 75‑238.
United States. National Commission on Marihuana and Drug Abuse. Marihuana: A Signal of Misunderstanding. Washington, D.C.: Government Printing Office, 1972.
Acknowledgments
This book is the product of many years of research and writing, and I am grateful to the many people who have contributed to its completion. The librarians and archivists at the Library of Congress, the British Library, and the University of California, Berkeley, provided invaluable assistance in locating sources. My colleagues in the fields of history, anthropology, and pharmacology shared their expertise and their insights. The farmers, activists, and patients who shared their stories helped me to understand the human dimensions of this history. And my family supported me through the long process of writing, offering patience and encouragement when it was most needed.
Any errors of fact or interpretation are, of course, my own.
The history of cannabis is a history of human beings and their relationship with the natural world. It is a story that has unfolded across ten thousand years, across all the continents, and through all the civilizations that have shaped human experience. It is a story that is still unfolding, and its future is being written in the choices that we make today. May this book contribute to a deeper understanding of that history and of the plant that has been our companion for so long.
Comments
Post a Comment
Let us get your thoughts 💚👨🍳💨